BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016; 22(34): 7824-7840 [PMID: 27678366 DOI: 10.3748/wjg.v22.i34.7824]
URL: https://www.wjgnet.com/1948-5182/full/v22/i34/7824.htm
Number Citing Articles
1
Chikako Yamamoto, Shintaro Nagashima, Channarena Chuon, Ko Ko, Son Huy Do, Oline Lim, Sirany Hok, Somana Svay, Junko Matsuo, Keiko Katayama, Kazuaki Takahashi, Junko Tanaka. Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in CambodiaViruses 2020; 12(5): 551 doi: 10.3390/v12050551
2
Hailong Wang, Xiu Xin, Mingzhen Wang, Lingling Han, Jiadai Li, Yao Hao, Congyi Zheng, Chao Shen. Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activationArchives of Virology 2018; 163(6): 1429 doi: 10.1007/s00705-018-3748-3
3
Vera Holzmayer, Russell Taylor, Mary C. Kuhns, Susan H. Gawel, Nicaise Ndembi, Dora Mbanya, Lazare Kaptue, Mary A. Rodgers, Gavin Cloherty. Evaluation of hepatitis C virus antibody assay using dried blood spot samplesScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-07821-0
4
Ming‐Lung Yu, Wei‐Lun Tsai, Chi‐Jen Chu, Jia‐Horng Kao. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study The Kaohsiung Journal of Medical Sciences 2021; 37(3): 245 doi: 10.1002/kjm2.12317
5
Michael Bowsher, Sheldon Hiebert, Rongti Li, Alan X. Wang, Jacques Friborg, Fei Yu, Dennis Hernandez, Ying-Kai Wang, Herbert Klei, Ramkumar Rajamani, Kathy Mosure, Jay O. Knipe, Nicholas A. Meanwell, Fiona McPhee, Paul M. Scola. The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 proteaseBioorganic & Medicinal Chemistry Letters 2018; 28(1): 43 doi: 10.1016/j.bmcl.2017.11.005
6
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCVJournal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
7
Fahimeh Ranjbar Kermani, Sedigheh Amini-Kafiabad, Kamran Mousavi Hosseini, Mahtab Maghsudlu, Zohreh Sharifi, Mohammad Ali Mansournia. Distribution of Hepatitis C Virus Genotypes and Related Risk Factors Among Iranian Blood Donors: A Penalized Logistic RegressionJundishapur Journal of Microbiology 2018; 11(12) doi: 10.5812/jjm.69136
8
Luis Antonio Uribe-Noguez, Alicia Ocaña-Mondragón, José Antonio Mata-Marín, María Elena Gómez-Torres, Rosa María Ribas-Aparicio, María de la Luz Martínez-Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencingJournal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
9
Suhail H Al-Amad. Willingness of dentists in the United Arab Emirates to perform restorative and surgical treatments for patients infected with hepatitis CArchives of Public Health 2021; 79(1) doi: 10.1186/s13690-021-00756-4
10
Irina Volinsky, Salvo Danilo Lombardo, Paz Cheredman. Stability Analysis and Cauchy Matrix of a Mathematical Model of Hepatitis B Virus with Control on Immune System near Neighborhood of Equilibrium Free PointSymmetry 2021; 13(2): 166 doi: 10.3390/sym13020166
11
Benli Jia, Yong Wang, Gang Yu, Yunsheng Cheng, Chuang Yang, Feng Cao, Yan He, Pengwei Cao, Xiangling Meng, Dongsheng Yu. Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liverBiomedicine & Pharmacotherapy 2019; 115: 108848 doi: 10.1016/j.biopha.2019.108848
12
Paul Alain Tagnouokam-Ngoupo, Marie Nicole Ngoufack, Sebastien Kenmoe, Simon Frédéric Lissock, Marie Amougou-Atsama, Robert Banai, Laure Ngono, Richard Njouom. Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patientsVirology Journal 2019; 16(1) doi: 10.1186/s12985-019-1214-9
13
Nadine Ahmed, Noreen Ahmed, Roxana Filip, John Paul Pezacki. Nuclear Receptors2021; : 315 doi: 10.1007/978-3-030-78315-0_13
14
Arnolfo Petruzziello, Rocco Sabatino, Giovanna Loquercio, Annunziata Guzzo, Lucia Di Capua, Francesco Labonia, Anna Cozzolino, Rosa Azzaro, Gerardo Botti, Yury E. Khudyakov. Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern ItalyPLOS ONE 2019; 14(2): e0212033 doi: 10.1371/journal.pone.0212033
15
Nelson Veiga Gonçalves, Claudia do Socorro Carvalho Miranda, Juan Andrade Guedes, Larissa de Cássia Tork da Silva, Elizabeth Maciel Barros, Cileide Gomes da Mota Tavares, Vera Regina da Cunha Menezes Palácios, Simone Beverly Nascimento da Costa, Helena Cunha Oliveira, Marília Brasil Xavier. Hepatites B e C nas áreas de três Centros Regionais de Saúde do Estado do Pará, Brasil: uma análise espacial, epidemiológica e socioeconômicaCadernos Saúde Coletiva 2019; 27(1): 1 doi: 10.1590/1414-462x201900010394
16
Stephen Ejeh, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi. In Silico Design, Drug-Likeness and ADMET Properties Estimation of Some Substituted Thienopyrimidines as HCV NS3/4A Protease InhibitorsChemistry Africa 2021; 4(3): 563 doi: 10.1007/s42250-021-00250-y
17
Luis Antonio Uribe-Noguez, Alicia Ocaña-Mondragón, José Antonio Mata-Marín, Allison Cázares-Cortázar, Rosa María Ribas-Aparicio, María Elena Gómez-Torres, Jesus Gaytán-Martínez, María de la Luz Martínez-Rodríguez. Case report: Identification of recombinant HCV genotype 1b–2b by viral sequencing in two patients with treatment failure, who responded to re-treatment with sofosbuvir and daclatasvirJournal of Infection and Chemotherapy 2018; 24(11): 928 doi: 10.1016/j.jiac.2018.04.001
18
Resat Ozaras, Hakan Leblebicioglu. Viral Hepatitis: Chronic Hepatitis C2019; : 1 doi: 10.1007/978-3-030-03757-4_1
19
Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, Larry A. Mole, Lisa I. Backus. Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3Journal of Hepatology 2019; 70(1): 15 doi: 10.1016/j.jhep.2018.09.018
20
T. Joseph Mattingly, Bryan L. Love, Bilal Khokhar. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic reviewPharmacoEconomics 2020; 38(9): 927 doi: 10.1007/s40273-020-00933-3
21
Mohammad Sultan Khuroo. Viral Hepatitis: Acute Hepatitis2019; : 77 doi: 10.1007/978-3-030-03535-8_6
22
Nelba T. G. P. Miranda, Ronaldo L. Souza, Jacqueline C. Monteiro, Iran B. Costa, Leonardo Q. Siravenha, Anderson L. B. Luz, Núbia C. C. Almeida, Aldemir B. Oliveira‐Filho, Rogério V. Laurentino, Luiz F. A. Machado. Seroprevalence of HBV and HCV in female sex workers from four cities in the state of Pará, northern BrazilJournal of Medical Virology 2021; 93(6): 3730 doi: 10.1002/jmv.26759
23
Sanja Matic, Suzana Popovic, Dejan Baskic, Danijela Todorovic, Nenad Vukovic, Milan Stankovic, Predrag Djurdjevic, Nemanja Zdravkovic, Zeljko Mijailovic. Methanolic Extract of Teucrium Polium Exerts Immunomodulatory Properties in Human Peripheral Blood Mononuclear CellsSerbian Journal of Experimental and Clinical Research 2020; 0(0) doi: 10.2478/sjecr-2020-0018
24
Ali Ghasemi, Maryam Zadsar, Mojgan Shaiegan, Shahram Samiei, Ali Namvar, Mahboobeh Rasouli, Molood Moosanejad. Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis CJournal of Medical Virology 2020; 92(1): 45 doi: 10.1002/jmv.25423
25
Jin Won Kwon, Ha Jin Tchoe, Jayoun Lee, Jae Kyung Suh, Jeong-Hoon Lee, Sangjin Shin. The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in KoreaGut and Liver 2020; 14(1): 108 doi: 10.5009/gnl18522
26
Berhanu Elfu Feleke, Teferi Elfu Feleke, Wondimu Gebrekiros Adane, Abel Girma. Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort studyVirology Journal 2020; 17(1) doi: 10.1186/s12985-020-01385-z
27
Natasha K. Martin, Lara K. Marquez. Disease Modelling and Public Health, Part BHandbook of Statistics 2017; 37: 93 doi: 10.1016/bs.host.2017.08.007
28
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2
29
Na He, Gong Feng, Shuai Hao, Meiqi Xu, Jing Liu, Fanjiao Kong, Zhuoxu Ren, Wenli Dou, Chengzi Yao, Tian Liang, Juan Wang. The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: A meta-analysisAnnals of Hepatology 2022; 27(4): 100705 doi: 10.1016/j.aohep.2022.100705
30
Ahmed Arafa, Ehab S. Eshak, Tarek A. Abdel Rahman, Manal M. Anwar. Hepatitis C virus infection and risk of pancreatic cancer: A meta-analysisCancer Epidemiology 2020; 65: 101691 doi: 10.1016/j.canep.2020.101691
31
Tarek Mohamed Kamal Motawi, Dina Sabry, Nagwa Ibrahim Shehata, Mira Magdy William, Atef Tadros Fahim. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV‐related hepatocellular carcinoma in EgyptiansJournal of Biochemical and Molecular Toxicology 2022; 36(3) doi: 10.1002/jbt.22965
32
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and PathogenesisJournal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
33
M. Conti, T. Matulli Cavedagna, E. Ramazzotti, R. Mancini, L. Calza, M. Rinaldi, L. Badia, V. Guardigni, P. Viale, G. Verucchi. Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC–MS/MSClinical Mass Spectrometry 2018; 7: 6 doi: 10.1016/j.clinms.2017.12.002
34
Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan Ball, Jean Dubuisson, Steven K.H. Foung, Arvind H. Patel, Mats A.A. Persson, Geert Leroux-Roels, Philip Meuleman. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1Virology 2018; 514: 30 doi: 10.1016/j.virol.2017.10.019
35
Abdel-Rahman N. Zekri, Abeer A. Bahnassy, Mona S. Abdellateif. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76763
36
Jae-Cheol Kwon, Hye Young Chang, Oh Young Kwon, Ji Hoon Park, In Soo Oh, Hyung Joon Kim, Jun Hyung Lee, Ha-Jung Roh, Hyun Woong Lee. Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in KoreaYonsei Medical Journal 2018; 59(9): 1072 doi: 10.3349/ymj.2018.59.9.1072
37
Cesar Henriquez-Camacho, Núria Serre, Francesca Norman, Adrián Sánchez-Montalvá, Diego Torrús, Ane Josune Goikoetxea, Juan María Herrero-Martínez, José Manuel Ruiz-Giardín, Begoña Treviño, Begoña Monge-Maillo, Israel Molina, Azucena Rodríguez, Magdalena García, Rogelio López-Vélez, José A. Pérez-Molina, Paloma Aguilera, María Martínez Serrano, Magdalena García Rodriguez, Marta Díaz Menendez, Yolanda Meije, Joaquim Martínez-Montauti, Xavier Sanz, Isabel Pacheco Tenza, Inmaculada Gonzalez Cuello, Belén Martínez López, Jara LLenas, Mar Masiá, Sergio Padilla, Mónica Romero, Philip Wilkman-Jorgensen, Diego Torrús, José Manuel Ramos Rincón, Eduardo Malmierca, Ana Perez-Ayala, Juan María Herrero, Manuel Lizasoain, Pablo Rojo, Mariano Matarranz, Carlos Zarco, Azucena Rodriguez-Guardado, Jonathan Fernández Suárez, Jose Antonio Boga Ribeiro, Josune Goikoetxea Aguirre, Miren Zuriñe Zubero Sulibarría, José Manuel Ruiz Giardin, Juan Victor Sanmartín López, María Velasco Arribas, Eva Calabuig Muñoz, Ana Mena Ribas, María Peñaranda Vera, Israel Molina, Adrián Sánchez Montalvá, Fernando Salvador, Ángel Dominguez, Francesca Norman, Begoña Treviño-Maruri, Nuria Serre Delcor, Antonio Soriano-Arandes, Diana Pou Ciruelo, Cristina Bocanegra. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi networkTravel Medicine and Infectious Disease 2019; 29: 51 doi: 10.1016/j.tmaid.2019.02.001
38
Jia-Horng Kao, Chun-Yen Lin, Wan-Long Chuang, Yao-Yun Cheng, Jui-Yu Hu, Wen-Kai Liang, Peter Friebe, Stuart Palmer, Chin-Shiou Huang. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotypingDiagnostic Microbiology and Infectious Disease 2019; 94(4): 344 doi: 10.1016/j.diagmicrobio.2019.02.020
39
Eyasu Alem Lake, Robera Olana Fite, Lielt Gebreselassie Gebrekirstos, Meron Hadis Gebremedhin, Mohammed Suleiman Obsa, Kelemu Abebe Gelaw. Seroprevalence of hepatitis c virus infection among blood donors in Ethiopia: a systematic review and meta-analysisBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-05827-z
40
Jian Zhang, Wen Sun, Jun Lin, Ye Tian, Linlin Ma, Lei Zhang, Yichen Zhu, Wei Qiu. Long-term follow-up of HCV infected kidney transplant recipients receiving direct-acting antiviral agents: a single-center experience in ChinaBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4217-7
41
Geison Luiz Costa de Castro, Ednelza da Graça Silva Amoras, Mauro Sérgio Moura de Araújo, Simone Regina Souza da Silva Conde, Antonio Carlos R. Vallinoto. Hepatitis C virus genotypes and associated risk factors in the state of Pará, Northern BrazilThe Brazilian Journal of Infectious Diseases 2020; 24(4): 304 doi: 10.1016/j.bjid.2020.06.010
42
Huiying Rao, Huixin Liu, Elizabeth Wu, Ming Yang, Bo Feng, Andy Lin, Ran Fei, Robert J. Fontana, Lai Wei, Anna S. Lok. Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis CJHEP Reports 2020; 2(4): 100136 doi: 10.1016/j.jhepr.2020.100136
43
P Guntipalli, R Pakala, S Kumari Gara, F Ahmed, A Bhatnagar, M.-K. Endaya Coronel, A.A. Razzack, A.G. Solimando, A Thompson, K Andrews, G Enebong Nya, S Ahmed, R Ranaldo, R Cozzolongo, E Shahini. Worldwide prevalence, genotype distribution and management of hepatitis CActa Gastro Enterologica Belgica 2021; 84(4): 633 doi: 10.51821/84.4.015
44
Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young-Suk Lim, Yock Young Dan, Ming-Lung Yu, Maria Stepanova. Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East AsiaAlimentary Pharmacology & Therapeutics 2019; 49(6): 644 doi: 10.1111/apt.15131
45
Rania A. Zayed, Dalia Omran, Abeer A. Zayed, Lobna O. Elmessery. Determinants of Infection Outcome in HCV-Genotype 4Viral Immunology 2017; 30(8): 560 doi: 10.1089/vim.2017.0071
46
Dhruv Verma, Carina Ashkar, Sammy Saab. Cost effectiveness of direct acting antivirals in the treatment of hepatitis C in vulnerable populationsExpert Review of Pharmacoeconomics & Outcomes Research 2021; 21(1): 9 doi: 10.1080/14737167.2021.1838898
47
Ahmed Salman, Mohamed A. Salman, Amr M. Ismaeel Saadawy, Mohamed Tourky, Mohamed Shawkat. Portal venous hemodynamics as predictors for the development and grades of esophageal varices in Post‐HCV cirrhotic patients: An Egyptian center study Advances in Digestive Medicine 2021; 8(3): 146 doi: 10.1002/aid2.13209
48
Ali Nada, Aliaa Sabry, Naglaa S. Elabd, Azza M. Abdu Allah, Nada Elnaidany, Mohamed Abbasy. B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levelsEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00133-4
49
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest ChinaWorld Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
50
Muhammad Sarfaraz Iqbal, Usman Ali Ashfaq, Sadia Aslam, Saba Khaliq, Muhammad Usman Ghani, Farzana Batool. Analysis of polymorphism rs1990760 of IFIH1 gene and treatment outcomes in HCV infectionFuture Virology 2018; 13(3): 181 doi: 10.2217/fvl-2017-0116
51
Beatriz Torres-Vázquez, Ana María de Lucas, Carlos García-Crespo, Juan Antonio García-Martín, Adrián Fragoso, María Fernández-Algar, Celia Perales, Esteban Domingo, Miguel Moreno, Carlos Briones. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell CultureJournal of Molecular Biology 2022; 434(7): 167501 doi: 10.1016/j.jmb.2022.167501
52
Roberto da Justa Pires Neto, Elodie Bomfim Hyppolito, Geraldo Bezerra da Silva Junior. Tropical Nephrology2020; : 193 doi: 10.1007/978-3-030-44500-3_15
53
Sonia Vázquez-Morón, Beatriz Ardizone Jiménez, María A. Jiménez-Sousa, José M. Bellón, Pablo Ryan, Salvador Resino. Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysisScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41139-8
54
Anjali Prashar. Shed Tears for Diagnostics2019; : 51 doi: 10.1007/978-981-13-7169-1_5
55
Xiumei Chi, Moli Wang, Yu Pan, Jing Jiang, Tao Jiang, Hongqing Yan, Ruihong Wu, Xiaomei Wang, Xiuzhu Gao, Junqi Niu. Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferonJournal of Gastroenterology and Hepatology 2020; 35(1): 97 doi: 10.1111/jgh.14812
56
Baomin Liu, Kuo Gai, Hui Qin, Xushi Liu, Yuan Cao, Qin Lu, Dandan Lu, Deyang Chen, Hengqiao Shen, Wei Song, Yang Zhang, Xiaojin Wang, Hongjiang Xu, Yinsheng Zhang. Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activityEuropean Journal of Medicinal Chemistry 2018; 148: 95 doi: 10.1016/j.ejmech.2018.02.025
57
Neemat M. Kassem, Hebatallah A. Kassem, Magdy Ibrahim, Hussam Zawam, Emad Hamada. The clinical impact of hepatitis C virus infection in Egyptian multiple myeloma patientsJournal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-00054-0
58
Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter Angus, Edward Gane, Jia‐Horng Kao, Parvez S. Mantry, David Mutimer, K. Rajender Reddy, Tram T. Tran, Yiran B. Hu, Abhishek Gulati, Preethi Krishnan, Emily O. Dumas, Ariel Porcalla, Nancy S. Shulman, Wei Liu, Suvajit Samanta, Roger Trinh, Xavier Forns. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus InfectionHepatology 2018; 68(4): 1298 doi: 10.1002/hep.30046
59
Maria John, Seema Oommen, Ozhiparambhil Anilkumar Jagan, Sincy George, Sivan Pillai. A Study on the Circulating Genotypes of Hepatitis C Virus in a Tertiary Care Hospital in Central KeralaIndian Journal of Medical Microbiology 2018; 36(4): 532 doi: 10.4103/ijmm.IJMM_18_239
60
Yucel Aydin, Milad Chedid, Srinivas Chava, Donkita Danielle Williams, Shuanghu Liu, Curt H. Hagedorn, Suchitra Sumitran-Holgersson, Krzysztof Reiss, Krzysztof Moroz, Hua Lu, Luis A. Balart, Srikanta Dash. RETRACTED ARTICLE: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV cultureScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10087-6
61
Ying-Wen Wang, Wei-Ping Lee, Yi-Hsiang Huang, Ming-Chih Hou, Keng-Hsin Lan. Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysisBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06657-9
62
Brandon Wiggins, Smit Deliwala, Fady Banno, Kyle Knight, Mark Minaudo. Acute Renal Failure and Nephrotic Syndrome Secondary to Collapsing Glomerulopathy Associated With Hepatitis CCureus 2022;  doi: 10.7759/cureus.23175
63
Sanhua Wei, Yingfeng Lei, Jie Yang, Xiaoyan Wang, Fang Shu, Xin Wei, Fang Lin, Bin Li, Ying Cui, Hai Zhang, Sanhua Wei. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopesVaccine 2018; 36(17): 2273 doi: 10.1016/j.vaccine.2018.03.036
64
Mona Abdel-Hady, Deirdre A. Kelly. Encyclopedia of Gastroenterology2020; : 113 doi: 10.1016/B978-0-12-801238-3.65710-0
65
Vito Emanuele Catania, Giulia Malaguarnera, Giorgia Fiorenza, Eleonora Margherita Chisari, Anna Rita Lipari, Valentino Gallina, Manuela Pennisi, Giuseppe Lanza, Michele Malaguarnera. Hepatitis C Virus Infection Increases Fatigue in Health Care WorkersDiseases 2020; 8(4): 37 doi: 10.3390/diseases8040037
66
Idris Abdullahi Nasir, Sa’adatu Yakubu, Jelili Olaide Mustapha. Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus CoinfectionVirology: Research and Treatment 2017; 8: 1178122X1772441 doi: 10.1177/1178122X17724411
67
Asma Akhter, Mahwish Javed, Muhammad Imran. Comparative Analysis of PCR and LIPA Method for HCV Genotypes ScreeningBioScientific Review 2019; 1(04): 29 doi: 10.32350/BSR.0104.04
68
Mohamed F. Montasser, Samy Zaky, Mohamed Salaheldin, Dina Johar, Abdelrahman Ibrahim Abushouk, Fathiya El-Raey, Muneer Al-Husseini, Elsayed G. Mohammed. Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus PatientsJournal of Interferon & Cytokine Research 2019; 39(2): 85 doi: 10.1089/jir.2018.0131
69
Edwin N. Okafor, Innocent N. Okonkwo, Martin C. Ugonabo, Ekene E. Chukwukelu, Obiageli U. Odurukwe, Sussan N. Osiri. Emerging risk factors associated with prevalence of hepatitis c virus infection among Nigerians: Findings from blood donors in an academic hospital, Enugu South‐Eastern NigeriaInternational Journal of Clinical Practice 2020; 74(3) doi: 10.1111/ijcp.13460
70
Guy Rostoker. When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?Seminars in Dialysis 2019; 32(1): 22 doi: 10.1111/sdi.12732
71
Netanel Tzarum, Ian A. Wilson, Mansun Law. The Neutralizing Face of Hepatitis C Virus E2 Envelope GlycoproteinFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01315
72
Murat OCAL, Mehmet Emin BULUT. Determination of anti-HCV signal to cut-off value in patients with hepatitis C virus infection and the variety of antibody responsesThe European Research Journal 2022; : 1 doi: 10.18621/eurj.945588
73
Ming-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, Chun-Chi Kao, Cheng-Yuan Peng, Hsueh-Chou Lai, Po-Heng Chuang, Jung-Ta Kao. Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort studyTherapeutic Advances in Chronic Disease 2022; 13: 204062232110676 doi: 10.1177/20406223211067631
74
Mohamed Abd Ellatif Afifi, Ahmed Mohamed Hussein, Mahmoud Rizk, Dirk Uhlmann. Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver CirrhosisInternational Journal of Hepatology 2021; 2021: 1 doi: 10.1155/2021/6669527
75
Satya P. Gupta. Studies on Hepatitis Viruses2018; : 1 doi: 10.1016/B978-0-12-813330-9.00001-6
76
A.I.K. Mahanama, B. Samaraweera, T.T. Niroshanie, S.S.S.A.K. Seethagala, J.I. Abeynayake. Seroprevalence of hepatitis B and C virus infection among clinically suspected patients at state sector hospitals in Sri Lanka; a laboratory-based retrospective studyInfectious Diseases 2019; 51(9): 706 doi: 10.1080/23744235.2019.1640387
77
Nahla Fadl, Tamer Z. Salem. Hepatitis C genotype 4: A report on resistance‐associated substitutions inNS3,NS5A,andNS5BgenesReviews in Medical Virology 2020; 30(4) doi: 10.1002/rmv.2120
78
Andreza Soriano Figueiredo, Elisabeth Lampe, Pedro Pereira Lira Furtado de Albuquerque, Flávia Löwen Levy Chalhoub, Ana Maria Bispo de Filippis, Livia Melo Villar, Oswaldo Gonçalves Cruz, Marcelo Alves Pinto, Jaqueline Mendes de Oliveira. Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, BrazilInfection, Genetics and Evolution 2018; 59: 38 doi: 10.1016/j.meegid.2018.01.017
79
Mary Malebranche, Dawn King, Jennifer Leonard. Descriptive epidemiology of hepatitis C in individuals referred for specialized HCV care in Newfoundland and Labrador, 1996–2014Canadian Liver Journal 2018; 1(3): 107 doi: 10.3138/canlivj.2018-0013
80
Sarwat Mahmud, Silva P. Kouyoumjian, Zaina Al Kanaani, Hiam Chemaitelly, Laith J. Abu-Raddad. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesisAnnals of Epidemiology 2018; 28(7): 452 doi: 10.1016/j.annepidem.2018.03.007
81
Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, Monserrat Cosme-Chávez, Sonia Roman. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)Annals of Hepatology 2021; 20: 100292 doi: 10.1016/j.aohep.2020.100292
82
Luis Antonio Uribe-Noguez, José Antonio Mata-Marín, Alicia Ocaña-Mondragón, Ericka Nelly Pompa-Mera, Rosa María Ribas-Aparicio, Carla Ileana Arroyo-Anduiza, María Elena Gomez-Torres, Alberto Chaparro-Sánchez, Jesus Gaytán-Martínez, Stefan Mauss. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in MexicoJournal of Infection and Chemotherapy 2020; 26(2): 205 doi: 10.1016/j.jiac.2019.08.009
83
Vincent Roumy, Lastenia Ruiz, Juan Celidonio Ruiz Macedo, Andrea-Luz Gutierrez-Choquevilca, Jennifer Samaillie, Leonor Arévalo Encinas, Wilfredo Ruiz Mesia, Hivelli Ericka Ricopa Cotrina, Céline Rivière, Sevser Sahpaz, Simon Bordage, Guillaume Garçon, Jean Dubuisson, Sebastien Anthérieu, Karin Seron, Thierry Hennebelle. Viral hepatitis in the Peruvian Amazon: Ethnomedical context and phytomedical resourceJournal of Ethnopharmacology 2020; 255: 112735 doi: 10.1016/j.jep.2020.112735
84
Muhammad Usman Ashraf, Kanzal Iman, Muhammad Farhan Khalid, Hafiz Muhammad Salman, Talha Shafi, Momal Rafi, Nida Javaid, Rashid Hussain, Fayyaz Ahmad, Syed Shahzad‐Ul‐Hussan, Shaper Mirza, Muhammad Shafiq, Samia Afzal, Sadia Hamera, Saima Anwar, Romena Qazi, Muhammad Idrees, Sohail A. Qureshi, Safee Ullah Chaudhary. Evolution of efficacious pangenotypic hepatitis C virus therapiesMedicinal Research Reviews 2019; 39(3): 1091 doi: 10.1002/med.21554
85
Kholoud A. Elkashef, Wafaa A. Emam, Noha M. Mesbah, Dina M. Abo-Elmatty, Asmaa R. Abdel-Hamed. Prevalence of Occult Hepatitis C Virus Infection in Egyptian Patients with Lymphoma: A New VisionDiagnostics 2022; 12(4): 1015 doi: 10.3390/diagnostics12041015
86
Page Axley, Zunirah Ahmed, Sujan Ravi, Ashwani K. Singal. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative ReviewJournal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00067
87
Yange Lang, Fangfang Li, Qiang Liu, Zhiqiang Xia, Zhenglin Ji, Juan Hu, Yuting Cheng, Minjun Gao, Fang Sun, Bingzheng Shen, Chang Xie, Wei Yi, Yingliang Wu, Jing Yao, Zhijian Cao. The Kv1.3 ion channel acts as a host factor restricting viral entryThe FASEB Journal 2021; 35(2) doi: 10.1096/fj.202000879RR
88
Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, James A. McCubrey, Melchiorre Cervello. GSK-3 in liver diseases: Friend or foe?Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020; 1867(9): 118743 doi: 10.1016/j.bbamcr.2020.118743
89
Hamid Heidarian Miri, Pooria Fazeli, Mohammad Ali-Hassanzadeh, Peyman Bemani, Dieter Kabelitz, Kurosh Kalantar. Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysisArchives of Virology 2021; 166(9): 2469 doi: 10.1007/s00705-021-05141-8
90
Priya Madan Yabaji, Aruna Shankarkumar, Akash Shukla, Shobna Bhatia. Hepatitis C Virus Infection in a Tertiary Care Hospital in Mumbai, India: Identification of a Mixed and Novel GenotypeIndian Journal of Medical Microbiology 2018; 36(3): 352 doi: 10.4103/ijmm.IJMM_18_221
91
Hsu-Heng Yen, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Fang-Chi Yang, Fu-Yuan Siao, Mei-Wen Chen, Pei-Yuan Su. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness AnalysisJournal of Clinical Medicine 2022; 11(7): 1853 doi: 10.3390/jcm11071853
92
ROBERT S. EGERMAN. New Antiviral Agents for Treatment of Hepatitis CClinical Obstetrics & Gynecology 2019; 62(4): 823 doi: 10.1097/GRF.0000000000000457
93
Rosangela Gaze, Luiz Carlos Fadel de Vasconcellos. Exposicao ocupacional à hepatite C: saber operário e rotas inexploradas de propagação do vírusRevista Brasileira de Saúde Ocupacional 2020; 45 doi: 10.1590/2317-6369000015319
94
P Huang, CH Wang, LY Zhuo, XS Xia, S Yang, JW Zhang, HZ Fan, JJ Wu, R Yu, M Yue, Y Zhang. Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populationsBritish Journal of Biomedical Science 2020; 77(3): 112 doi: 10.1080/09674845.2020.1747182
95
O. C. Smibert, M. A. Paraskeva, G. Westall, Greg Snell. An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant RecipientsPediatric Drugs 2018; 20(6): 539 doi: 10.1007/s40272-018-0313-1
96
Ahmad Adebayo Irekeola, Nurul Adila Malek, Yusuf Wada, Nazri Mustaffa, Nur Izat Muhamad, Rafidah Hanim Shueb, Isabelle Chemin. Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysisPLOS ONE 2021; 16(5): e0251673 doi: 10.1371/journal.pone.0251673
97
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen. Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal DiseasesIntestinal Research 2020; 18(1): 18 doi: 10.5217/ir.2019.09155
98
Reem M. Aljowaie, Fahad N. Almajhdi, Hebatallh H. Ali, Mohammad S. El-Wetidy, Medhat K. Shier. Inhibition of hepatitis C virus genotype 4 replication using siRNA targeted to the viral core region and the CD81 cellular receptorCell Stress and Chaperones 2020; 25(2): 345 doi: 10.1007/s12192-020-01077-1
99
Serge Ouoba, Jean Claude Romaric Pingdwinde Ouedraogo, Moussa Lingani, Bunthen E, Md Razeen Ashraf Hussain, Ko Ko, Shintaro Nagashima, Aya Sugiyama, Tomoyuki Akita, Halidou Tinto, Junko Tanaka. Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysisBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06817-x
100
Henrique Pott, Guilherme Bricks, Jorge Figueiredo Senise, Adauto Castelo. Chronic alcohol abuse and spontaneous clearance of hepatitis C virusIDCases 2019; 17: e00534 doi: 10.1016/j.idcr.2019.e00534
101
E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, T. V. Tyrinova, N. M. Starostina, A. A. Ostanin. Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-αRussian Journal of Infection and Immunity 2019; 9(1): 76 doi: 10.15789/2220-7619-2019-1-76-86
102
Letitia Shunmugam, Pritika Ramharack, Mahmoud E. S. Soliman. Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease InhibitorsThe Protein Journal 2017; 36(5): 397 doi: 10.1007/s10930-017-9736-8
103
Francesca Ceccherini-Silberstein, Valeria Cento, Velia Chiara Di Maio, Carlo Federico Perno, Antonio Craxì. Viral resistance in HCV infectionCurrent Opinion in Virology 2018; 32: 115 doi: 10.1016/j.coviro.2018.10.005
104
William B. Coleman, Gregory J. Tsongalis. Molecular Pathology2018; : 231 doi: 10.1016/B978-0-12-802761-5.00012-2
105
Vasil B. Krapchev, Malgorzata Rychłowska, Alicja Chmielewska, Karolina Zimmer, Arvind H. Patel, Krystyna Bieńkowska-Szewczyk. Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in miceVirology 2018; 519: 33 doi: 10.1016/j.virol.2018.03.026
106
Radwa Samir Hagag, Morkoss Medhat Fakhry, Ossama Ashraf Ahmed, Shaimaa Abdalaleem Abdalgeleel, Mahasen Aly Radwan, Gina Gamal Naguib. Assessment of efficacy and safety of two Egyptian protocols for treatment-experienced HCV patients: an observational studyThe Egyptian Journal of Internal Medicine 2022; 34(1) doi: 10.1186/s43162-022-00126-8
107
Zabihollah Shoja, Maryam Chenari, Ali Jafarpour, Somayeh Jalilvand. Role of iron in cancer development by virusesReviews in Medical Virology 2019; : e2045 doi: 10.1002/rmv.2045
108
Yeimer Ortiz-Martínez, Santiago Castellanos-Mateus, Heiner Rojas-Moreno, Justin Suárez-Molina. YouTube videos as a source of Hepatitis C-related information: A cross-sectional studyTravel Medicine and Infectious Disease 2020; 37: 101708 doi: 10.1016/j.tmaid.2020.101708
109
Rui Huang, Huiying Rao, Qing Xie, Zhiliang Gao, Wu Li, Deyuan Jiang, Hongmei Mo, Benedetta Massetto, Luisa M. Stamm, Diana M. Brainard, Lai Wei. Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionJournal of Medical Virology 2019; 91(7): 1313 doi: 10.1002/jmv.25454
110
Taciana Pereira Sant'Ana Santos, Mariana de Menezes Pereira, Maria Isabel Schinoni, Geraldo Pedral Sampaio, Roque Aras, Maria Luiza Sousa Atta, Ajax M. Atta. Atherogenic cytokines and chemokines in chronic hepatitis C are not associated with the presence of cardiovascular diseasesCytokine 2019; 115: 24 doi: 10.1016/j.cyto.2018.12.005
111
Jiuhong Zha, Bifeng Ding, Haoyu Wang, Weihan Zhao, Chen Yu, Katia Alves, Niloufar Mobashery, Yan Luo, Rajeev M. Menon. Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese PatientsEuropean Journal of Drug Metabolism and Pharmacokinetics 2019; 44(1): 43 doi: 10.1007/s13318-018-0492-8
112
Ivan Alekseevich Akimov, D. I. Timofeev, A. R. Mavzyutov, M. K. Ivanov. Detection of circulating HCV recombinant form RF1_2k/1b in blood serum of patients by real-time RT-PCRRussian Clinical Laboratory Diagnostics 2021; 66(2): 122 doi: 10.51620/0869-2084-2021-66-2-122-128
113
Yoshimi Shimizu, Yoshitaka Shirasago, Masuo Kondoh, Tetsuro Suzuki, Takaji Wakita, Kentaro Hanada, Kiyohito Yagi, Masayoshi Fukasawa, Michael S. Diamond. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse ModelJournal of Virology 2018; 92(8) doi: 10.1128/JVI.02258-17
114
Keyla Santos Guedes de Sá, Ednelza da Silva Graça Amoras, Simone Regina Souza da Silva Conde, Maria Alice Freitas Queiroz, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis CViruses 2021; 13(6): 1103 doi: 10.3390/v13061103
115
Netanel Tzarum, Erick Giang, Rameshwar U. Kadam, Fang Chen, Kenna Nagy, Elias H. Augestad, Rodrigo Velázquez-Moctezuma, Zhen-Yong Keck, Yuanzi Hua, Robyn L. Stanfield, Marlene Dreux, Jannick Prentoe, Steven K. H. Foung, Jens Bukh, Ian A. Wilson, Mansun Law. An alternate conformation of HCV E2 neutralizing face as an additional vaccine targetScience Advances 2020; 6(30) doi: 10.1126/sciadv.abb5642
116
Faisal Ismail, Soghra Haq, Islam El-Garawani, Eman Abdelsameea. Hepatitis C Virus Infection in Eastern Libya: Efforts Needed to Improve HCV Testing and Linkage to Care in the Resource-Limited SettingTropical Medicine and Infectious Disease 2022; 7(2): 14 doi: 10.3390/tropicalmed7020014
117
Monjur Ahmed. Era of direct acting anti-viral agents for the treatment of hepatitis CWorld Journal of Hepatology 2018; 10(10): 670-684 doi: 10.4254/wjh.v10.i10.670
118
Yu-Lung Chiu, Herng-Ching Lin, Nai-Wen Kuo, Senyong Kao, Hsin-Chien Lee. Increased risk of concurrent hepatitis C among Male patients with schizophreniaPsychiatry Research 2017; 258: 217 doi: 10.1016/j.psychres.2017.08.036
119
Momoko Iwamoto, Aurelie Calzia, Amelie Dublineau, François Rouet, Janin Nouhin, Sokchea Yann, Sophorn Pin, Chhorvy Sun, Kimchamroeun Sann, Chhit Dimanche, Celine Lastrucci, Rebecca M. Coulborn, David Maman, Jean-Philippe Dousset, Anne Loarec. Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in CambodiaJournal of Viral Hepatitis 2019; 26(1): 38 doi: 10.1111/jvh.13002
120
Kiyotaka Yamazaki, Dendy Macaulay, Yan Song, Yuri Sanchez Gonzalez. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims DataInfectious Diseases and Therapy 2019; 8(2): 285 doi: 10.1007/s40121-019-0234-5
121
Nirmal Kumar, Suchitra S. Prabhu, Isha Monga, Indranil Banerjee. Influence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysisMeta Gene 2021; 29: 100909 doi: 10.1016/j.mgene.2021.100909
122
Yucel Aydin, Christopher M. Stephens, Srinivas Chava, Zahra Heidari, Rajesh Panigrahi, Donkita D. Williams, Kylar Wiltz, Antoinette Bell, Wallace Wilson, Krzysztof Reiss, Srikanta Dash. Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell CultureThe American Journal of Pathology 2018; 188(10): 2339 doi: 10.1016/j.ajpath.2018.06.022
123
M. I. Valetskyi, M. U. Zak, O. V. Chernyshov, M. V. Sverdlova, V. S. Potochniak. Chronic Viral Hepatitis C: The Evolution of Scientific ViewsUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(5): 9 doi: 10.26693/jmbs05.05.009
124
Zuzana Macek Jilkova, Komal Saleem, Samia Afzal, Thomas Decaens. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCVLivers 2021; 1(4): 313 doi: 10.3390/livers1040024
125
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, Emily Corbould, Jeffrey V. Lazarus, Laura Webber, Nick Sheron. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policiesJournal of Hepatology 2018; 69(3): 718 doi: 10.1016/j.jhep.2018.05.011
126
Ryuichi Kumata, Jumpei Ito, Kenta Takahashi, Tadaki Suzuki, Kei Sato. A tissue level atlas of the healthy human viromeBMC Biology 2020; 18(1) doi: 10.1186/s12915-020-00785-5
127
Sana Riaz, Hira Tiwana, Muhammad Adil, Khaver Ali, Tariq Javed. Anti-hepatitis C virus and synergistic potential of Syzgium cumine a bioassay guided screening in liver-infected hepatocytesArchives of Microbiology 2022; 204(1) doi: 10.1007/s00203-021-02646-3
128
Malgorzata Pawlowska, Malgorzata Sobolewska-Pilarczyk, Krzysztof Domagalski. Hepatitis C virus infection in children in the era of direct-acting antiviralWorld Journal of Gastroenterology 2018; 24(24): 2555-2566 doi: 10.3748/wjg.v24.i24.2555
129
Dong Wook Jekarl, Hyunyu Choi, Seungok Lee, Jung Hyun Kwon, Sung Won Lee, Hein Yu, Myungshin Kim, Yonggoo Kim, Pil Soo Sung, Seung Kew Yoon. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B PatientsAnnals of Laboratory Medicine 2018; 38(4): 348 doi: 10.3343/alm.2018.38.4.348
130
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospectsEuropean Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
131
Mohamed A. Daw. Hepatitis C in Developing Countries2018; : 57 doi: 10.1016/B978-0-12-803233-6.00006-0
132
Sepideh Nasimzadeh, Azarakhsh Azaran, Shahram Jalilian, Manoochehr Makvandi, Seyed Saeid Seyedian, Bijan keikhaei, Fateme Jahangiri Mehr. Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, IranArchives of Virology 2021; 166(10): 2703 doi: 10.1007/s00705-021-05126-7
133
Babiker Saad Almugadam, Omer Mohammed Ali Ibrahim, Yousif Mousa Alobaid Ahmed. Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology HospitalMedicines 2021; 8(11): 64 doi: 10.3390/medicines8110064
134
Víctor Granados-García, Yvonne N. Flores, Lizbeth I. Díaz-Trejo, Lucia Méndez-Sánchez, Stephanie Liu, Guillermo Salinas-Escudero, Filiberto Toledano-Toledano, Jorge Salmerón, Vincenzo De Luca. Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysisPLOS ONE 2019; 14(2): e0212558 doi: 10.1371/journal.pone.0212558
135
Jin Zhang, Xing Gao, Yuan Yuan, Chao Sun, Yuanlin Zhao, Liming Xiao, Ying Yang, Yu Gu, Risheng Yang, Peizhen Hu, Lijun Zhang, Chao Wang, Jing Ye. Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liverLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1022-7
136
Ekta Gupta, Jasmine Samal, Amit Pandey, Gaurav Singh, Hajra A. S. Gupta, Reshu Agarwal, Manoj Kumar Sharma. Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV/HIV Co-Infected Patients: A Pilot Study from INDIAViruses 2022; 14(5): 944 doi: 10.3390/v14050944
137
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular CarcinomaThe Open Virology Journal 2018; 12(1): 26 doi: 10.2174/1874357901812010026
138
Marisa Silbernagl, Rudolf Slamanig, Gabriele Fischer, Laura Brandt. Hepatitis C infection and psychiatric burden in two imprisoned cohorts: Young offenders and opioid-maintained prisonersHealth Policy 2018; 122(12): 1392 doi: 10.1016/j.healthpol.2018.10.005
139
Andrew H Talal, Phyllis Andrews, Anthony Mcleod, Yang Chen, Clewert Sylvester, Marianthi Markatou, Lawrence S Brown. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on MethadoneClinical Infectious Diseases 2019; 69(2): 323 doi: 10.1093/cid/ciy899
140
Anissa Chouikha, Marwa Khedhiri, Hatem Triki, Walid Hammemi, Amel Sadraoui, Henda Touzi, Ahlem Ben Yahia, Amel Chtourou, Saba Gargouri, Lamia Feki Ben Rajah, Hela Hakim Karray, Henda Triki. Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective studyArchives of Virology 2021; 166(2): 501 doi: 10.1007/s00705-020-04918-7
141
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeInfectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
142
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis CDiagnostics 2020; 10(12): 1037 doi: 10.3390/diagnostics10121037
143
Kyung-Ah Kim, June Sung Lee. Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination SurveyGut and Liver 2020; 14(5): 644 doi: 10.5009/gnl19272
144
Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed. Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic controlEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00061-9
145
Aleena Haqqi, Rimsha Munir, Muhammad Khalid, Muhammad Khurram, Muhammad Zaid, Muhammad Ali, Zaheer Hussain Shah, Haroon Ahmed, Muhammad Sohail Afzal. Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of LiteratureViral Immunology 2019; 32(9): 402 doi: 10.1089/vim.2019.0058
146
Amina Adadi, Safae Adadi, Mohammed Berrada. Gastroenterology Meets Machine Learning: Status Quo and Quo VadisAdvances in Bioinformatics 2019; 2019: 1 doi: 10.1155/2019/1870975
147
Aisha Noreen, Naik Alam, Zainab Syed, Aroosa Aftab, Farah Shamim, Syed Najeebullah, Dilawar Khan, Salik Javed Kakar, Tahir Ahmed, Fazal Adnan. Prevalence and assessment of associated risk factors of hepatitis B and C infections in low-socioeconomic communitiesFuture Virology 2022; 17(5): 291 doi: 10.2217/fvl-2021-0060
148
Luigi Elio Adinolfi, Emanuele Durante Mangoni, Aldo Marrone, Rosa Zampino, Luca Rinaldi. Liver Diseases2020; : 181 doi: 10.1007/978-3-030-24432-3_17
149
Tasuku Okui. An age-period-cohort analysis of mortality rates for stomach, colorectal, liver, and lung cancer among prefectures in Japan, 1999–2018Environmental Health and Preventive Medicine 2020; 25(1) doi: 10.1186/s12199-020-00922-0
150
Sharda Patra, Kanika Chopra. Infections and Pregnancy2022; : 151 doi: 10.1007/978-981-16-7865-3_12
151
Chun-Yuan Lee, Pei-Hua Wu, Meng-Wei Lu, Tun-Chieh Chen, Po-Liang Lu, Kimberly Page. High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in TaiwanPLOS ONE 2021; 16(5): e0251158 doi: 10.1371/journal.pone.0251158
152
David Greenhalgh, Nader Al‐Rashidi. Modeling the spread of hepatitis C virus amongst people who inject drugsEngineering Reports 2022;  doi: 10.1002/eng2.12503
153
Qi Xia, Zheyue Shu, Ting Ye, Min Zhang. Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular CarcinomaFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.595699
154
Lucy Somerville, Karen Doucette. Hepatitis C: Current Controversies and Future Potential in Solid Organ TransplantationCurrent Infectious Disease Reports 2018; 20(7) doi: 10.1007/s11908-018-0625-x
155
Ajit Sood, A. Suryaprasad, A. Trickey, S. Kanchi, V. Midha, M. A. Foster, E. Bennett, S. Kamili, F. Alvarez-Bognar, S. Shadaker, V. Surlikar, R. Garg, P. Mittal, S. Sharma, M. T. May, P. Vickerman, F. Averhoff, Sibnarayan Datta. The burden of hepatitis C virus infection in Punjab, India: A population-based serosurveyPLOS ONE 2018; 13(7): e0200461 doi: 10.1371/journal.pone.0200461
156
Massimo Giuseppe Colombo, Erkin Isakovich Musabaev, Umed Yusupovich Ismailov, Igor A Zaytsev, Alexander V Nersesov, Igor Anatoliyevich Anastasiy, Igor Alexandrovich Karpov, Olga A Golubovska, Kulpash S Kaliaskarova, Ravishankar AC, Sanjay Hadigal. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regionsWorld Journal of Gastroenterology 2019; 25(29): 3897-3919 doi: 10.3748/wjg.v25.i29.3897
157
Lynnette Bhebhe, Motswedi Anderson, Sajini Souda, Wonderful T. Choga, Edward Zumbika, Zachary M. Shaver, Tshepiso Mbangiwa, Bonolo B. Phinius, Chabeni C. Banda, Pinkie Melamu, Rosemary M. Musonda, Max Essex, Jason T. Blackard, Sikhulile Moyo, Simani Gaseitsiwe. Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional studyBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4514-1
158
Mohamed B Hashem, Hedy A Badary, Noha A Mahfouz, Shaden Adel, Mohamed Alboraie, Mohamed AbdAllah, Wafaa AlAkel, Ramy Saeed, Islam Ammar, Wael Abdel-Razek, Mohamed Hassany, Gamal Esmat. Evaluation of factors affecting patients’ refusal of HCV treatment in a cohort of Egyptian patientsJournal of Public Health 2021;  doi: 10.1093/pubmed/fdab363
159
Qinglong Zhao, Shan Jiang, Meina Li, Laishun Yao, Xiaoyu Ma, Meng Li, Changcong Wang, Yingan Pan, Hantong Zhao, Bo Li. Incidence trend and age-period-cohort analysis of reported hepatitis C among residents aged 30 to 79 in northeastern China, 2008 to 2017Medicine 2020; 99(36): e22005 doi: 10.1097/MD.0000000000022005
160
Mahdi Mohamadi, Kimia Azarbayjani, Sayed‐Hamidreza Mozhgani, Taravat Bamdad, Ashkan Alamdary, Hadi Razavi Nikoo, Tayebeh Hashempour, Mojtaba Hedayat Yaghoobi, Mehdi Ajorloo. Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesisJournal of Medical Virology 2020; 92(12): 2930 doi: 10.1002/jmv.26091
161
You-Wen Tan, Yan Tao, Long-Gen Liu, Yun Ye, Xin-Bei Zhou, Li Chen, Cong He. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period surveyWorld Journal of Gastroenterology 2018; 24(11): 1250-1258 doi: 10.3748/wjg.v24.i11.1250
162
V. S. Kichatova, K. K. Kyuregyan, N. V. Soboleva, A. A. Karlsen, O. V. Isaeva, M. G. Isaguliants, M. I. Mikhailov. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic ContextJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7685371
163
Zana Sidiq Mohammed Saleem, Ibrahim A Naqid, Nawfal R Hussein, Sidra Jalal Mohammad, Jajeen Shaaban Noaman, Rajeen Salih Haji, Vin Ahmed Haji, Zainnab Muhsin Hussein, Piran Hussamaldin Mohammed. The Prevalence of Hepatitis B and C Virus in Patients With End-Stage Kidney Disease on Regular Hemodialysis in Duhok, Iraq: A Brief ReportAvicenna Journal of Clinical Microbiology and Infection 2020; 7(1): 31 doi: 10.34172/ajcmi.2020.06
164
Ylenia Pérez Castaño, José Manuel Chouza Pérez, Vanesa Sanz Largo, Edurne Almandoz Cortajarena, Alexandra Gómez García, Francisco Javier Esandi González, Agustín Castiella Eguzkiza, Sandra Arranz Díaz, Itxaso Urtasun Lugea, Maria José Sánchez Iturri, Borja Gil Fernández, Luis Bujanda , Juan Arenas Ruiz-Tapiador. Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in GipuzkoaRevista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.7194/2020
165
Jose Ramiro Cruz, Rene Berrios Cruz, Jorge Duque Rodríguez, Silvina Kuperman. Blood Safety2019; : 225 doi: 10.1007/978-3-319-94436-4_12
166
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen, Salman Nusrat. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosisEuropean Journal of Gastroenterology & Hepatology 2018; 30(3): 296 doi: 10.1097/MEG.0000000000001032
167
Matthew J. Akiyama, Abbe Muller, Owen Huang, John Lizcano, Mercy Nyakowa, Lindsey Riback, Jonathan Ross, Henry Bundi, Euphrasia Shitachi Kulabi, Ann Muthoni Mwangi, Helgar Musyoki, Peter Cherutich, Ann Kurth. Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative studyGlobal Public Health 2021; : 1 doi: 10.1080/17441692.2021.1896763
168
Takuya Sho, Goki Suda, Megumi Kimura, Tomoe Shimazaki, Osamu Maehara, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Machiko Umemura, Takaaki Izumi, Naoki Kawagishi, Masaru Baba, Masato Nakai, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto. Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three CasesInternal Medicine 2019; 58(6): 797 doi: 10.2169/internalmedicine.1856-18
169
Akari Kaba, Shigeyoshi Yamanaga, Yuji Hidaka, Mariko Toyoda, Masayuki Kashima, Yoshi Takekuma, Akito Inadome, Hiroshi Yokomizo, Akira Miyata. Glecaprevir/Pibrentasvir and Renal Dysfunction in Deceased Donor Renal Transplantation: A Case ReportTransplantation Proceedings 2022; 54(2): 549 doi: 10.1016/j.transproceed.2021.12.028
170
Phearavin Pheng, Laurence Meyer, Olivier Ségéral, Phalla Chea, Siyan Yi, Sovannary Tuot, John M. Kaldor, Vonthanak Saphonn. Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral surveyBMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07163-2
171
Dinesh Jothimani, Silas Danielraj, Gomathy Narasimhan, Ilankumaran Kaliamoorthy, Akila Rajakumar, Kumar Palaniappan, Swetha Palanichamy, Ashwin Rammohan, Hemalatha Ramachandran, Rajesh Rajalingam, Mohamed Rela. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in IndiaJournal of Clinical and Experimental Hepatology 2022; 12(3): 908 doi: 10.1016/j.jceh.2021.09.017
172
Mirela Pavicic Ivelja, Kresimir Dolic, Leida Tandara, Nikola Perkovic, Antonio Mestrovic, Ivo Ivic. Blood markers of endothelial dysfunction and their correlation to cerebrovascular reactivity in patients with chronic hepatitis C infectionPeerJ 2021; 9: e10723 doi: 10.7717/peerj.10723
173
Wondmagegn Demsiss, Abdurahaman Seid, Temesgen Fiseha, Isabelle Chemin. Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast EthiopiaPLOS ONE 2018; 13(5): e0196539 doi: 10.1371/journal.pone.0196539
174
Muhammad Umar Sohail, Asma A Al Thani, Hadi Mohamad Yassine. Comparative Phylogenetic and Residue Analysis of Hepatitis C Virus E1 Protein from the Middle East and North Africa RegionHepatitis Monthly 2019; 19(8) doi: 10.5812/hepatmon.92437
175
Ahmad Shakeri, Narthaanan Srimurugathasan, Katie J. Suda, Tara Gomes, Mina Tadrous. Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018Value in Health 2020; 23(9): 1137 doi: 10.1016/j.jval.2020.03.021
176
Claudia Monica Danilescu, Daniela Larisa Sandulescu, Mihail Cristian Pirlog, Costin Teodor Streba, Ion Rogoveanu. Depressive and Anxious Symptoms in Hepatitis C Virus Infected Patients Receiving DAA-Based TherapyDiagnostics 2021; 11(12): 2237 doi: 10.3390/diagnostics11122237
177
William W.L. Wong, Josephine Wong, Karen E. Bremner, Yasmin Saeed, Kate Mason, Arcturus Phoon, Zeny Feng, Jordan J. Feld, Nicholas Mitsakakis, Jeff Powis, Murray Krahn. Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health SystemValue in Health 2022; 25(2): 247 doi: 10.1016/j.jval.2021.08.006
178
Amen Bawazir, Fahad AlGusheri, Hoda Jradi, Mohammed AlBalwi, Abdel-Galil Abdel-Gader. Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profileVirology Journal 2017; 14(1) doi: 10.1186/s12985-017-0873-7
179
Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, Stefania Canova, Jessica Menis, Alfredo Addeo, Antonio Russo, Diego Luigi Cortinovis. Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selectionCritical Reviews in Oncology/Hematology 2018; 129: 27 doi: 10.1016/j.critrevonc.2018.06.016
180
Abdool S. Yasseen, Jeffrey C. Kwong, Jordan J. Feld, Naveed Z. Janjua, Christina Greenaway, Lauren Lapointe‐Shaw, Morris Sherman, Tony Mazzulli, Rafal Kustra, Liane MacDonald, Beate Sander, Natasha S. Crowcroft. Viral hepatitis C cascade of care: A population‐level comparison of immigrant and long‐term residentsLiver International 2021; 41(8): 1775 doi: 10.1111/liv.14840
181
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Nicola Coppola, Mauro Piccirillo, Maddalena Leongito, Rosa Azzaro, Francesco Izzo, Gerardo Botti. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective studyInfectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0162-5
182
Adam Trickey, Hannah Fraser, Aaron G Lim, Amy Peacock, Samantha Colledge, Josephine G Walker, Janni Leung, Jason Grebely, Sarah Larney, Natasha K Martin, Matthew Hickman, Louisa Degenhardt, Margaret T May, Peter Vickerman. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyThe Lancet Gastroenterology & Hepatology 2019; 4(6): 435 doi: 10.1016/S2468-1253(19)30085-8
183
Corrine I. Voils, Heather A. King, Carolyn T. Thorpe, Dan V. Blalock, Ian M. Kronish, Bryce B. Reeve, Colleen Boatright, Ziad F. Gellad. Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C TreatmentDigestive Diseases and Sciences 2019; 64(10): 2784 doi: 10.1007/s10620-019-05621-7
184
Petra Simicic, Ivana Grgic, Maja Santak, Adriana Vince, Snjezana Zidovec Lepej. Frequency of baseline NS5A resistance-associated substitutions in patients infected with genotype 1 of hepatitis C virus in CroatiaMicrobial Pathogenesis 2019; 136: 103694 doi: 10.1016/j.micpath.2019.103694
185
Gaitan Fabrice Njiomegnie, Scott A. Read, Nicole Fewings, Jacob George, Fiona McKay, Golo Ahlenstiel. Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV InfectionJournal of Clinical Medicine 2020; 9(4): 1030 doi: 10.3390/jcm9041030
186
Zuzana Macek Jílková, Arnaud Seigneurin, Celine Coppard, Laurissa Ouaguia, Caroline Aspord, Patrice N. Marche, Vincent Leroy, Thomas Decaens. Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting AntiviralsCancers 2020; 12(12): 3820 doi: 10.3390/cancers12123820
187
Alexander Gutwerk, Thomas Wex, Kerstin Stein, Cosima Langner, Ali Canbay, Peter Malfertheiner, Alexander Link. Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide PolymorphismJournal of Clinical Medicine 2018; 7(3): 44 doi: 10.3390/jcm7030044
188
Faisal Abaalkhail, Waleed Al-hamoudi, Ibrahim Altraif, Hazem Mohamed, Hassan Aleid, Dieter Broering, Saleh Alqahtani. Treatment with Grazoprevir/Elbasvir in Post-kidney Transplant Patients with Hepatitis C Virus Genotype 4 InfectionHepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.110260
189
Daniel Candotti, Virginie Sauvage, Pierre Cappy, Mohamed Abdallahi Boullahi, Pascal Bizimana, Guy Olivier Mbensa, Sekou Oumar Coulibaly, Aimée Olivat Rakoto Alson, Hadiza Soumana, Claude Tagny‐Tayou, Edward L. Murphy, Syria Laperche. High rate of hepatitis C virus and human immunodeficiency virus false‐positive results in serologic screening in sub‐Saharan Africa: adverse impact on the blood supplyTransfusion 2020; 60(1): 106 doi: 10.1111/trf.15593
190
Albert Do, Nancy S. Reau. Chronic Viral Hepatitis: Current Management and Future DirectionsHepatology Communications 2020; 4(3): 329 doi: 10.1002/hep4.1480
191
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi, Mattia Mori. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design ChallengeMolecules 2020; 25(23): 5695 doi: 10.3390/molecules25235695
192
Abdulrahman Alduraywish, Mostafa Ragheb, Ibrahim Taher, Nageh Louis, Khaled Aldossari, Rania Kishk. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional studyScandinavian Journal of Gastroenterology 2020; 55(8): 963 doi: 10.1080/00365521.2020.1790649
193
Juliana Reyes‐Urueña, Ana Celly, Sergio Moreno, Xavier Majó, Joan Colom, Jordi Casabona. Hepatitis C virus: Testing rate and attrition at linkage to specialized care, Catalonia, Spain 2011‐2016Journal of Viral Hepatitis 2021; 28(2): 288 doi: 10.1111/jvh.13427
194
Batbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ping-Hsin Hsieh, Wan-Long Chuang, Jin-Ching Lee, Ming-Lung Yu, Chia-Yen Dai. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis CJournal of the Chinese Medical Association 2019; 82(4): 277 doi: 10.1097/JCMA.0000000000000064
195
Maher BM. Boraie, Yasser A. Elnaggar, Mohammed Othman Ahmed, Ahmed M. Mahmoud. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study)Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4): 2641 doi: 10.1016/j.dsx.2019.07.032
196
Yun Lu, Xiuze Jin, Cheng-a-xin Duan, Feng Chang, Yury E Khudyakov. Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in ChinaPLOS ONE 2018; 13(4): e0195117 doi: 10.1371/journal.pone.0195117
197
Ana Elisa de Figueiredo Miranda Mundim, Fernanda de Oliveira Feitosa de de Castro, Marina Brandão Braz Albuquerque, Cesar Augusto Sam Tiago Vilanova-Costa, Irmtraut Araci Hoffmann Pfrimer, Antonio Márcio Teodoro Cordeiro Silva. Major mutations in the NS3 gene region of hepatitis C virus related to the resistance to direct acting antiviral drugs: a systematic reviewVirusDisease 2020; 31(3): 220 doi: 10.1007/s13337-020-00616-9
198
Zain Ul Abideen, Shafiqa Siddique, Izza Nasrullah, Jahangir S. Khan, Sidra Rehman, Yigang Tong, Raheel Qamar, Azeem M. Butt. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patientsEuropean Journal of Gastroenterology & Hepatology 2019; 31(9): 1103 doi: 10.1097/MEG.0000000000001384
199
V. Estrada, I. Sagastagoitia. Hepatitis C is a risk factor for cardiovascular diseaseRevista Clínica Española (English Edition) 2019; 219(6): 322 doi: 10.1016/j.rceng.2019.03.005
200
Stephen M. Davis, Danielle Davidov, Alfgeir L. Kristjansson, Keith Zullig, Adam Baus, Melanie Fisher, Nickolas Zaller. Qualitative case study of needle exchange programs in the Central Appalachian region of the United StatesPLOS ONE 2018; 13(10): e0205466 doi: 10.1371/journal.pone.0205466
201
Barrot H. Lambdin, Jennifer Lorvick, Jessie K. Mbwambo, John Rwegasha, Saria Hassan, Paula Lum, Alex H. Kral. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, TanzaniaInternational Journal of Drug Policy 2017; 45: 64 doi: 10.1016/j.drugpo.2017.05.043
202
Zahra Amirsardari, Farzaneh Rahmani, Nima Rezaei. Cognitive impairments in HCV infection: From pathogenesis to neuroimagingJournal of Clinical and Experimental Neuropsychology 2019; 41(10): 987 doi: 10.1080/13803395.2019.1652728
203
Mandana Namayandeh, Marzieh Jamalidoust, Nahid Heydari Marandi, Nasrin Aliabadi, Atoosa Ziyaeyan, Gholamreza Pouladfar, Mazyar Ziyaeyan. Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019Microbiology and Immunology 2020; 64(11): 762 doi: 10.1111/1348-0421.12845
204
Alexander M. Sy, Christopher B. O’Brien. Liver Failure2020; : 167 doi: 10.1007/978-3-030-50983-5_9
205
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, Devanand Sarkar. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 1 doi: 10.1016/bs.acr.2020.10.001
206
Crina Fofiu, Alina Boeriu, Felicia Coman, Alexandru Fofiu, Nikola Panic, Milutin Bulajic, Daniela Dobru. Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV PatientsAnnals of Hepatology 2019; 18(1): 137 doi: 10.5604/01.3001.0012.7905
207
Esther Babady. Molecular Monitoring of Viral InfectionsAdvances in Molecular Pathology 2018; 1(1): 65 doi: 10.1016/j.yamp.2018.06.006
208
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled TrialsJournal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
209
Sajjad Ahmad, Farah Shahid, Muhammad Tahir ul Qamar, Habib ur Rehman, Sumra Wajid Abbasi, Wasim Sajjad, Saba Ismail, Faris Alrumaihi, Khaled S. Allemailem, Ahmad Almatroudi, Hafiz Fahad Ullah Saeed. Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine DesignVaccines 2021; 9(3): 293 doi: 10.3390/vaccines9030293
210
Tatsuki Mizuochi, Tomoko Takano, Tadahiro Yanagi, Kosuke Ushijima, Mitsuyoshi Suzuki, Yoko Miyoshi, Yoshinori Ito, Ayano Inui, Hitoshi Tajiri. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in JapanJournal of Gastroenterology 2018; 53(3): 419 doi: 10.1007/s00535-017-1351-0
211
Shu-Mei Tsai, Jung-Ta Kao, Yun-Fang Tsai. Illness trajectory of initial infection for patients with hepatitis C: A qualitative studyNursing & Health Sciences 2019; 21(1): 112 doi: 10.1111/nhs.12568
212
John O. Link. HCV: The Journey from Discovery to a CureTopics in Medicinal Chemistry 2019; 32: 81 doi: 10.1007/7355_2019_67
213
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyondWorld Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
214
Z. M. Younossi, A. Tanaka, Y. Eguchi, L. Henry, R. Beckerman, M. Mizokami. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in JapanJournal of Viral Hepatitis 2018; 25(8): 945 doi: 10.1111/jvh.12886
215
H. Y. Choi, Y. Kim, H. Cho, B. H. Kim, M. Ki. Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002-2013: A population-based cohort studyJournal of Viral Hepatitis 2018; 25(3): 272 doi: 10.1111/jvh.12815
216
Kosuke Matsumoto, Hisamitsu Miyaaki, Masanori Fukushima, Ryu Sasaki, Masafumi Haraguchi, Satoshi Miuma, Kazuhiko Nakao. The impact of single‑nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct‑acting antiviral drugs for hepatitis C infectionBiomedical Reports 2021; 16(2) doi: 10.3892/br.2021.1492
217
Aiko Fukui, Naoto Kawabe, Senju Hashimoto, Hiroyuki Kamei, Kentaro Yoshioka. Skeletal muscle mass depletion in patients with hepatitis C virus infectionEuropean Journal of Gastroenterology & Hepatology 2019; 31(1): 59 doi: 10.1097/MEG.0000000000001255
218
James E. Squires, William F. Balistreri. Hepatitis C virus infection in children and adolescentsHepatology Communications 2017; 1(2): 87 doi: 10.1002/hep4.1028
219
Ariel Bardach, Akram Hernández-Vásquez, Alfredo Palacios, María Calderón, Natalie Soto, Dario Balan, Federico Augustovski. Epidemiology, Use of resources, and Costs of Medical Management of Hepatitis C in Argentina, Colombia, Uruguay, and VenezuelaValue in Health Regional Issues 2019; 20: 180 doi: 10.1016/j.vhri.2019.06.004
220
Jóice Teixeira de Bitencorte, Tássia Flores Rech, Vagner Ricardo Lunge, Deivid Cruz dos Santos, Mário Reis Álvares-da-Silva, Daniel Simon. Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infectionWorld Journal of Hepatology 2021; 13(1): 109-119 doi: 10.4254/wjh.v13.i1.109
221
Amanda Abdel-Al, Eman El-Ahwany, Mona Zoheiry, Marwa Hassan, Amged Ouf, Hoda Abu-Taleb, Ali Abdel Rahim, Mohamed Darwish El-Talkawy, Suher Zada. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patientsVirus Research 2018; 253: 135 doi: 10.1016/j.virusres.2018.06.007
222
Asmaa Abo Elgoud Said, Ahmed H. Afifi, Taha F. S. Ali, Mamdouh Nabil Samy, Usama Ramadan Abdelmohsen, Mostafa A. Fouad, Eman Zekry Attia. NS3/4A helicase inhibitory alkaloids from Aptenia cordifolia as HCV targetRSC Advances 2021; 11(52): 32740 doi: 10.1039/D1RA06139A
223
L H Zain, T Sungkar. Management of hepatitis C infection in the era of direct-acting antiviral therapyIOP Conference Series: Earth and Environmental Science 2018; 125: 012087 doi: 10.1088/1755-1315/125/1/012087
224
Amina A. Negash, Rebecca M. Olson, Stephen Griffin, Michael Gale, Christopher M. Walker. Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activationPLOS Pathogens 2019; 15(2): e1007593 doi: 10.1371/journal.ppat.1007593
225
Fei Kong, Xiaoyu Wen, Xiaofeng Wen, Xiaozhong Wang, Guicheng Wu, Shide Lin, Li Wang, Huichun Xing, Xuebing Yan, Sujun Zheng, Qin Ning, Zheng Wang, Liaoyun Zhang, Jianmei Lin, Zhaowei Tong, Chengyu Huang, Minghua Su, Lixin Tong, Jidong Jia, Yongning Xin, Qingjing Zhu, Jing Wang, Li Chen, Xiaowen Li, Xuegang Wu, Duan Niu, Quan Liu, Wei Wei, Yuexin Zhang, Guangming Li, Junqi Niu. Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single‐arm, open‐label, phase 3 trialJournal of Gastroenterology and Hepatology 2021; 36(9): 2375 doi: 10.1111/jgh.15412
226
Chia-Min Wu, Fu-Hsiung Su, Chih-Hsin Muo, Jou-Chen Huang, Meei-Maan Wu, Chih-Ching Yeh. Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus RibavirinViruses 2021; 13(3): 475 doi: 10.3390/v13030475
227
Tran Nguyen, Trang Pham, Hong K Tang, Loc Phan, Gary Mize, William M Lee, Robert Gish, Amy Trang, Anh Le, Hai T Phan, Binh T Nguyen, Doan Y Dao. Unmet needs in occupational health: prevention and management of viral hepatitis in healthcare workers in Ho Chi Minh City, Vietnam: a mixed-methods studyBMJ Open 2021; 11(10): e052668 doi: 10.1136/bmjopen-2021-052668
228
Chayan Bhattacharjee, Maitri Singh, Debisukti Das, Sujit Chaudhuri, Aparna Mukhopadhyay. Current therapeutics against HCVVirusDisease 2021; 32(2): 228 doi: 10.1007/s13337-021-00697-0
229
Jia Li, Stuart C. Gordon, Loralee B. Rupp, Talan Zhang, Sheri Trudeau, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Mei Lu. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetesAlimentary Pharmacology & Therapeutics 2019; 49(5): 599 doi: 10.1111/apt.15102
230
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron MetabolismCytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
231
Maria Alejandra Luna-Cuadros, Hao-Wei Chen, Hira Hanif, Mukarram Jamat Ali, Muzammil Muhammad Khan, Daryl Tan-Yeung Lau. Risk of hepatocellular carcinoma after hepatitis C virus cureWorld Journal of Gastroenterology 2022; 28(1): 96-107 doi: 10.3748/wjg.v28.i1.96
232
Lia Goncalves Possuelo, Daiane Perin, Patricia Faber Breunig, Daniel Felipe Schroeder, Manuela Filter Allgayer, Camilo Darsie, Marcelo Carneiro, Vanda Hermes, Jane Dagmar Pollo Renner. Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional studySao Paulo Medical Journal 2017; 136(2): 109 doi: 10.1590/1516-3180.2017.0169180917
233
Ahmed A. Ezat, Wael M. Elshemey. A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approachesLife Sciences 2019; 217: 176 doi: 10.1016/j.lfs.2018.12.004
234
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi, Rakesh Kumar. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another DimensionInternational Journal of Molecular Sciences 2017; 18(8): 1626 doi: 10.3390/ijms18081626
235
Dariush Naghipour-Khalkhaliani, Daryoush Behzadpour, Seyed Dawood Mousavi Nasab. Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of IranHepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.62030
236
Jacob D. de Boer, Hein Putter, Joris J. Blok, Nouvel A. Cambridge, Simen D. van den Berg, Serge Vogelaar, Gabriela Berlakovich, Markus Guba, Andries E. Braat, ELIAC Eurotransplant Liver and Intestine Advisory Committee. Development of the Eurotransplant Discard Risk Index to Predict Acceptance of Livers for Transplantation: A Retrospective Database AnalysisExperimental and Clinical Transplantation 2021; 19(11): 1163 doi: 10.6002/ect.2021.0228
237
Rui Huang, Huiying Rao, Jia Shang, Hong Chen, Jun Li, Qing Xie, Zhiliang Gao, Lei Wang, Jia Wei, Jianning Jiang, Jian Sun, Jiaji Jiang, Lai Wei. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5DHealth and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0941-8
238
Dongxian Ye, Yuqing Tang, Yuanliang Gu, Harris Haleem, Libo Zhang, Youping Zhang, Chunxia Xu, Jinshun Zhao. Evaluation of the effectiveness of a pilot study of hospital-based hepatitis C epidemic surveillanceMedicine 2019; 98(51): e18334 doi: 10.1097/MD.0000000000018334
239
Silvia Nardelli, Oliviero Riggio, Davide Rosati, Stefania Gioia, Alessio Farcomeni, Lorenzo Ridola. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptomsWorld Journal of Gastroenterology 2019; 25(48): 6928-6938 doi: 10.3748/wjg.v25.i48.6928
240
William B. Coleman, Gregory J. Tsongalis. Essential Concepts in Molecular Pathology2020; : 191 doi: 10.1016/B978-0-12-813257-9.00012-7
241
Arwa Kamhawy, Zeinab Nabil Ahmed Said, Salwa Elsayed Abdelhamid, Mohammad El-Sayed, Rasha Eletreby, Hasan El Garem, Mohamed El Kassas, Gamal Esmat. Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antiviralsArab Journal of Gastroenterology 2021; 22(2): 158 doi: 10.1016/j.ajg.2021.03.001
242
Sarmad Zahoor, Aleena Khan, Sadia Asif, Sair Ahmad Tabraiz, Hossam Mustafa, Sheraz Ansar, Sumera Hanif, Hassan Ali Raza. Past and Future Perspectives for Hepatitis B and C in PakistanCureus 2021;  doi: 10.7759/cureus.17521
243
Hailang Li, Ling Hu, Liwen Wang, Yixuan Wang, Meiqi Shao, Yupei Chen, Wenlin Wu, Lei Wang. Iron Activates cGAS-STING Signaling and Promotes Hepatic InflammationJournal of Agricultural and Food Chemistry 2022; 70(7): 2211 doi: 10.1021/acs.jafc.1c06681
244
Elizabeth Buganza-Torio, Karen Elizabeth Doucette. Management of Viral Hepatitis in Solid Organ Transplant RecipientsInfectious Disease Clinics of North America 2018; 32(3): 635 doi: 10.1016/j.idc.2018.04.010
245
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factorsAPMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
246
V. S. Kichatova, A. A. Karlsen, O. V. Isaeva, S. A. Solonin, E. Yu. Malinnikova, K. K. Kyuregyan, M. I. Mikhailov. Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteinsJournal Infectology 2018; 10(4): 30 doi: 10.22625/2072-6732-2018-10-4-30-36
247
Shahab Mahmoudvand, Somayeh Shokri, Azarakhsh Azaran, Seyed S. Seyedian, Manoochehr Makvandi, Habibollah Mirzaei, Sheida B. Sheikhrobat. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence studyTherapeutic Apheresis and Dialysis 2021; 25(2): 218 doi: 10.1111/1744-9987.13535
248
Hairui Zhang, Ran Ren, Jinlin Liu, Ying Mao, Guowei Pan, Ke Men, Li Ma. Health-Related Quality of Life among Patients with Hepatitis C Virus Infection: A Cross-Sectional Study in Jianping County of Liaoning Province, ChinaGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/6716103
249
Emily Nguyen, Sam Trinh, Huy Trinh, Huy Nguyen, Khanh Nguyen, Aivien Do, Brian Levitt, Son Do, My Nguyen, Treta Purohit, Eugenie Shieh, Mindie H. Nguyen. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvirAlimentary Pharmacology & Therapeutics 2019; 49(1): 99 doi: 10.1111/apt.15043
250
Andrey V. Barkhash, Galina V. Kochneva, Elena V. Chub, Aida G. Romaschenko. Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian populationMicrobes and Infection 2018; 20(3): 212 doi: 10.1016/j.micinf.2017.11.012
251
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Nei-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Jin-Ching Lee, Chia-Yen Dai. The effect of antiviral therapy on serum lipid profiles in chronic hepatitis COncotarget 2018; 9(30): 21313 doi: 10.18632/oncotarget.25092
252
Livia Melo Villar, Vanessa Salete de Paula, Barbara Vieira do Lago, Juliana Custódio Miguel, Helena Medina Cruz, Moyra Machado Portilho, Vanessa Alves Marques, Roberto Pérez Ravier, Ivana Lo Castro, Héctor Cuello, Carlos Espul. Epidemiology of hepatitis B and C virus infection in Central West ArgentinaArchives of Virology 2020; 165(4): 913 doi: 10.1007/s00705-020-04540-7
253
Hang Zhang, Ahmed A. Quadeer, Matthew R. McKay. Evolutionary modeling reveals enhanced mutational flexibility of HCV subtype 1b compared with 1aiScience 2022; 25(1): 103569 doi: 10.1016/j.isci.2021.103569
254
Jianjian Zhuang, Juxin Yin, Shaowu Lv, Ben Wang, Ying Mu. Advanced “lab-on-a-chip” to detect viruses – Current challenges and future perspectivesBiosensors and Bioelectronics 2020; 163: 112291 doi: 10.1016/j.bios.2020.112291
255
Muhammad Arba, Setyanto Tri Wahyudi, Muhammad Sulaiman Zubair, Dylan Brunt, Mursalin Singh, Chun Wu. Binding of GS-461203 and Its Halogen Derivatives to HCV Genotype 2a RNA Polymerase Drug Resistance MutantsScientia Pharmaceutica 2022; 90(2): 26 doi: 10.3390/scipharm90020026
256
Sara Lo Menzo, Enrico Biagi, Mariachiara Di Nuzzo, Anastasio Grilli, Carlo Contini. SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 PatientAnnals of Hepatology 2018; 17(4): 661 doi: 10.5604/01.3001.0012.0950
257
JC Jiménez-Mendoza, FE Rivera-López, MF González-Lara, RD Valdez-Echeverría, GE Castro-Narro, A Tore, LF Uscanga-Domínguez, C Moctezuma-Velázquez. Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in MexicoAnnals of Hepatology 2022; 27(3): 100684 doi: 10.1016/j.aohep.2022.100684
258
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in EgyptDiagnostic Microbiology and Infectious Disease 2018; 92(2): 107 doi: 10.1016/j.diagmicrobio.2018.05.013
259
Gary M. Clifford, Tim Waterboer, Bolormaa Dondog, You Lin Qiao, Dimitri Kordzaia, Doudja Hammouda, Namory Keita, Nahid Khodakarami, Syed Ahsan Raza, Ang Tshering Sherpa, Witold Zatonski, Michael Pawlita, Martyn Plummer, Silvia Franceschi. Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and AfricaInfectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0121-1
260
Mohan Krishna Ghanta, Mohammad Faiz Hussain, Asmita Karnalkar, Sirpu Natesh Nagabhishek, Poojith Nuthalapati, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 401 doi: 10.1016/B978-0-323-99283-1.00003-3
261
Petra E de Ruiter, Yashna Gadjradj, Robert J de Knegt, Herold J Metselaar, Jan NM Ijzermans, Luc JW van der Laan. Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acidWorld Journal of Transplantation 2018; 8(5): 156-166 doi: 10.5500/wjt.v8.i5.156
262
Maléki Assih, Abdoul Karim Ouattara, Birama Diarra, Albert Theophane Yonli, Tegwindé Rebeca Compaore, Dorcas Obiri-Yeboah, Florencia Wendkuuni Djigma, Simplice Karou, Jacques Simpore. Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018World Journal of Hepatology 2018; 10(11): 807-821 doi: 10.4254/wjh.v10.i11.807
263
Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon RegionPathogens 2019; 8(4): 236 doi: 10.3390/pathogens8040236
264
Zeina Nehme, Sébastien Pasquereau, Georges Herbein. Histone Modifications in Therapy2020; : 255 doi: 10.1016/B978-0-12-816422-8.00011-8
265
Carmen L. Loureiro, Rossana C. Jaspe, Flor H. Pujol. Variation in Hepatitis C Virus Subtype Distribution during 20 Years in VenezuelaIntervirology 2019; 62(5-6): 191 doi: 10.1159/000505065
266
Issam I Raad, Anne-Marie Chaftari, Harrys A Torres, Ehab Mouris Ayoub, Liliane Iskander Narouz, Jalen Bartek, Ray Hachem. Challenge of hepatitis C in Egypt and hepatitis B in MauritaniaWorld Journal of Hepatology 2018; 10(9): 549-557 doi: 10.4254/wjh.v10.i9.549
267
Ashly Maughan, Onyema Ogbuagu. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infectionExpert Opinion on Drug Metabolism & Toxicology 2018; 14(2): 219 doi: 10.1080/17425255.2018.1421173
268
Asrul Akmal Shafie, Muhammad Radzi Abu Hassan, Norazila Abdul Ghani, Beng Hoong Chew, Nor Syahireen Mohammed. Cost analysis of chronic hepatitis C virus management in a Malaysia tertiary hospitalJournal of Pharmaceutical Health Services Research 2018; 9(2): 141 doi: 10.1111/jphs.12210
269
Itai Yechezkel, Mansun Law, Netanel Tzarum. From Structural Studies to HCV Vaccine DesignViruses 2021; 13(5): 833 doi: 10.3390/v13050833
270
Lazzat Aibekova, Aizada Bexeitova, Arailym Aldabergenova, Gonzalo Hortelano, Zhangwen Ge, Feng Yi, Yiming Shao, Jack DeHovitz, Sten H. Vermund, Syed Ali. Transmission of HIV and HCV within Former Soviet Union CountriesCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/9701920
271
Antoine Chaillon, Sanjay R. Mehta, Martin Hoenigl, Sunil S. Solomon, Peter Vickerman, Matthew Hickman, Britt Skaathun, Natasha K. Martin, Yury E. Khudyakov. Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfectionPLOS ONE 2019; 14(6): e0217964 doi: 10.1371/journal.pone.0217964
272
Naveen Bhagat, Nipun Verma, Virendra Singh. HCC prediction post SVR in HCV patients: many tools yet limited generalizability!Journal of Hepatology 2022;  doi: 10.1016/j.jhep.2022.04.028
273
Guilherme Bricks, Jorge Figueiredo Senise, Henrique Pott Junior, Giuliano Grandi, Amanda Passarini, Débora Bellini Caldeira, Dimas Carnaúba Junior, Hamilton Antonio Bonilha de Moraes, Celso Franscisco Hernandes Granato, Adauto Castelo. Seroprevalence of hepatitis E virus in chronic hepatitis C in BrazilThe Brazilian Journal of Infectious Diseases 2018; 22(2): 85 doi: 10.1016/j.bjid.2018.02.001
274
Arzu ALTUNÇEKİÇ YILDIRIM, Celali KURT, Ali Seydi ALPAY, Ahmet DOĞAN. Genotype distribution and risk factors in patients with chronic hepatitis C infectionJOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH 2021;  doi: 10.34084/bshr.846410
275
Vahideh Takhviji, Ebrahim Azizi, Ali Kordian, Abbas Khosravi, Mostafa Paridar, Mohammad Ali Jalalifar, Omid Kiani Ghalehsardi, Mohammad Abdollahi, Mofid Hosseinzadeh, Zahra Bakshandeh. Hepatitis C virus prevalence among patients with thalassemia and inherited bleeding disorders in Iran: a systematic review and meta-analysisHematology & Transfusion International Journal 2018; 6(5) doi: 10.15406/htij.2018.06.00175
276
Flavia F. Fernandes, Hugo Perazzo, Luiz E. Andrade, Alessandra Dellavance, Carlos Terra, Gustavo Pereira, João L. Pereira, Frederico Campos, Maria L. Ferraz, Renata M. Perez. Latent Class Analysis of Noninvasive Methods and Liver Biopsy in Chronic Hepatitis C: An Approach without a Gold StandardBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/8252980
277
Xavier A. Andrade, Luis H. Paz, Mo''ath Nassar, Diana M. Oramas, Harry E. Fuentes, Paula Kovarik, Satya Mishra, Anshu Singh. Primary Liver Diffuse Large B-Cell Lymphoma following Complete Response for Hepatitis C Infection after Direct Antiviral TherapyActa Haematologica 2018; 139(2): 77 doi: 10.1159/000484653
278
Safaa S. Abo-Elnour, Amira E. Abdelhamid, Sherine E. Bendary, Ossama A. Ahmed, Heba I. Aly, Dina M. Erfan. Serum Interleukin-35 Level in Correlation with T Regulatory and T helper-17 Cells Frequency in Chronic Viral Hepatitis C PatientsJournal of Pure and Applied Microbiology 2020; 14(4): 2431 doi: 10.22207/JPAM.14.4.21
279
Satish Kumar, P. K. Santra, R. C. Aryan. SYNTHESIS CHARACTERIZATION AND DOCKING STUDY OF HCV NS3/4A PROTEASE INHIBITOR MOLECULESINDIAN DRUGS 2020; 57(05): 19 doi: 10.53879/id.57.05.12295
280
Larisa Denisa Ursu, Bogdan Calenic, Mircea Diculescu, Alina Dima, Iulia Teodora Stoian, Ileana Constantinescu. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patientsInternational Journal of Immunogenetics 2021; 48(1): 16 doi: 10.1111/iji.12515
281
Guy Rostoker, Nosratola D. Vaziri. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for cautionHemodialysis International 2017; 21: S68 doi: 10.1111/hdi.12557
282
Tawhida Y. Abdel Ghaffar, Suzan El Naghi, Manal Abdel Gawad, Sarah Helmy, Aisha Abdel Ghaffar, Medhat Yousef, Mohamad Moafy. Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4Journal of Viral Hepatitis 2019; 26(2): 263 doi: 10.1111/jvh.13032
283
Isaac Thom Shawa. Hepatitis B and C2020;  doi: 10.5772/intechopen.82772
284
Lara K Marquez, Javier A Cepeda, Annick Bórquez, Steffanie A Strathdee, Patricia E Gonzalez-Zúñiga, Clara Fleiz, Claudia Rafful, Richard S Garfein, Susan M Kiene, Stephanie Brodine, Natasha K Martin. Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysisInternational Journal of Drug Policy 2021; 88: 102710 doi: 10.1016/j.drugpo.2020.102710
285
V. Estrada, I. Sagastagoitia. La hepatitis C es un factor de riesgo para enfermedad cardiovascularRevista Clínica Española 2019; 219(6): 322 doi: 10.1016/j.rce.2019.01.012
286
Zujaja tul Misbah, Lubaba tul Uzma, Kanwal Shaheen, Tehreem Tanveer, Sadia Anjum. Prevalence of Skin diseases among Hepatitis C virus infected patients and their association with HCV infection in Islamabad, Pakistan2019 16th International Bhurban Conference on Applied Sciences and Technology (IBCAST) 2019; : 264 doi: 10.1109/IBCAST.2019.8667194
287
Yasuhiro Asahina, Chun‐Jen Liu, Edward Gane, Yoshito Itoh, Norifumi Kawada, Yoshiyuki Ueno, Jin Youn, Chen‐Yu Wang, Joe Llewellyn, Takuma Matsuda, Anuj Gaggar, Hongmei Mo, Hadas Dvory‐Sobol, Gerald Crans, Wan‐Long Chuang, Pei‐Jer Chen, Nobuyuki Enomoto. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsHepatology Research 2020; 50(10): 1109 doi: 10.1111/hepr.13546
288
X. M. LI, R. X. QIU, C. H. SONG, Q. H. HUANG, X. D. WANG, Z. T. HU, X. Z. HE, X. Y. YE, X. G. HUANG, F. F. ZHENG, G. X. LIN. Genotype and genetic variation of HCV infections with low-risk factors in Putian coastal regions, ChinaEpidemiology and Infection 2017; 145(16): 3385 doi: 10.1017/S0950268817002357
289
H Maqsood, Tamoor Chughtai, Abdul Basit Khan, Shifa Younus, Akifa Abbas, Usman A Akbar, Shaheryar Qazi. Association of Lipid and Body Mass Index Profile With Chronic Hepatitis C Infection Stratified by Age and GenderCureus 2021;  doi: 10.7759/cureus.20665
290
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and ProspectsVaccines 2020; 8(1): 90 doi: 10.3390/vaccines8010090
291
Ahmed Babiker, Jean Jeudy, Seth Kligerman, Miriam Khambaty, Anoop Shah, Shashwatee Bagchi. Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A ReviewJournal of Clinical and Translational Hepatology 2017; 5(4): 1 doi: 10.14218/JCTH.2017.00021
292
Marc Puigvehí, Beatriz De Cuenca, Ana Viu, Moisés Diago, Juan Turnes, Francisco Gea, Juan M. Pascasio, Sabela Lens, Joaquín Cabezas, Ester Badia, Antonio Olveira, Rosa M. Morillas, Xavier Torras, Silvia Montoliu, Patricia Cordero, José L. Castro, Javier Salmerón, Esther Molina, Juan J. Sánchez-Ruano, Javier Moreno, María D. Antón, José M. Moreno, Juan De la Vega, José L. Calleja, José A. Carrión. Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohortLiver International 2019; 39(1): 90 doi: 10.1111/liv.13950
293
Malathi Sathiyasekaran, Ganesh Ramaswamy. Diagnosis and Management of Hepatitis B and Hepatitis C Infections in Children Pediatric Infectious Disease 2020; 2(1): 12 doi: 10.5005/jp-journals-10081-1238
294
Ídila Mont’Alverne Xavier de Oliveira, Rita do Socorro Uchôa da Silva. Rheumatological Manifestations Associated with Viral Hepatitis B or CRevista da Sociedade Brasileira de Medicina Tropical 2019; 52 doi: 10.1590/0037-8682-0407-2018
295
Xiao Liu, Xiaoqiong Duan, Jacinta A. Holmes, Wenting Li, Sae Hwan Lee, Zeng Tu, Chuanlong Zhu, Shadi Salloum, Anna Lidofsky, Esperance A. Schaefer, Dachuan Cai, Shilin Li, Haoju Wang, Yongfu Huang, Yongju Zhao, Ming-Lung Yu, Zhiwen Xu, Limin Chen, Jian Hong, Wenyu Lin, Raymond T. Chung. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6Hepatology 2019; 69(3): 1004 doi: 10.1002/hep.30266
296
L Alexa Thompson, Jayne Fenton, Carmen L Charlton. HCV reflex testing: A single-sample, low-contamination method that improves the diagnostic efficiency of HCV among patients in Alberta, CanadaOfficial Journal of the Association of Medical Microbiology and Infectious Disease Canada 2022;  doi: 10.3138/jammi-2021-0028
297
Mary A Rodgers, Ana Olivo, Barbara J Harris, Chris Lark, Xinxin Luo, Michael G Berg, Todd V Meyer, Aurash Mohaimani, Gregory S Orf, Yitz Goldstein, Amy S Fox, Julie Hirschhorn, William B Glen, Frederick Nolte, Alan Landay, Cheryl Jennings, James Moy, Venice Servellita, Charles Chiu, Rahul Batra, Luke B Snell, Gaia Nebbia, Sam Douthwaite, Amilcar Tanuri, Lavanya Singh, Tulio de Oliveira, Ambroise Ahouidi, Souleymane Mboup, Gavin A Cloherty. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological testsJournal of Clinical Virology 2022; 147: 105080 doi: 10.1016/j.jcv.2022.105080
298
Zurabi Lominadze, Robert S. Brown. Acute HCV Treatment: What Should We Do in the DAA Era?Current Hepatology Reports 2019; 18(2): 216 doi: 10.1007/s11901-019-00463-3
299
Roseline MINME, Iandra HOLZMANN, Cristiane Valle TOVO, Paulo Roberto Lerias de ALMEIDA. PROFILE OF PATIENTS WITH CHRONIC HEPATITIS C IN A PUBLIC HEALTH PROGRAM IN SOUTHERN BRAZILArquivos de Gastroenterologia 2018; 55(4): 403 doi: 10.1590/s0004-2803.201800000-86
300
Mohammad S. Khuroo, Ahmad A. Sofi. The Discovery of Hepatitis Viruses: Agents and DiseaseJournal of Clinical and Experimental Hepatology 2020; 10(4): 391 doi: 10.1016/j.jceh.2020.04.006
301
Peter A.C. Wing, Meleri Jones, Michelle Cheung, Sampath DaSilva, Connor Bamford, Wing-Yiu Jason Lee, Elihu Aranday-Cortes, Ana Da Silva Filipe, John McLauchlan, David Smith, William Irving, Morven Cunningham, Azim Ansari, Eleanor Barnes, Graham R. Foster. Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirGastroenterology 2019; 157(3): 692 doi: 10.1053/j.gastro.2019.05.007
302
María Q. Marín, Kwinten Sliepen, Juan García-Arriaza, Sylvie M. Koekkoek, Patricia Pérez, Carlos Óscar S. Sorzano, Carmen E. Gómez, Rogier W. Sanders, Mariano Esteban. Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCVVaccines 2020; 8(3): 440 doi: 10.3390/vaccines8030440
303
Jihene Bettaieb, Anissa Chouikha, Marwa Khedhiri, Ghassen Kharroubi, Malek Badreddine, Nabil Bel Hadj Hmida, Adel Gharbi, Walid Hammemi, Amel Sadraoui, Ahlem Ben Yahia, Zina Meddeb, Afif Ben Salah, Henda Triki. Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional studyArchives of Virology 2019; 164(9): 2243 doi: 10.1007/s00705-019-04308-8
304
Reilly Hostager, Manon Ragonnet-Cronin, Ben Murrell, Charlotte Hedskog, Anu Osinusi, Simone Susser, Christoph Sarrazin, Evguenia Svarovskaia, Joel O Wertheim. Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineageVirus Evolution 2019; 5(2) doi: 10.1093/ve/vez041
305
Nor Asiah Muhamad, Rimah Melati Ab.Ghani, Mohd Hatta Abdul Mutalip, Eida Nurhadzira Muhammad, Hasmah Mohamad Haris, Rozainanee Mohd Zain, Noraidatulakma Abdullah, Nor Azila Muhammad Azami, Nazihah Abd Jalal, Norliza Ismail, Nurul Ain Mhd Yusuf, Raihannah Othman, Azwa Shawani Kamalul Arifin, Mohd Shaharom Abdullah, Mohd Arman Kamaruddin, Muhammad Radzi Abu Hassan, Tahir Aris, Rahman Jamal. Seroprevalence of hepatitis B virus and hepatitis C virus infection among Malaysian populationScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77813-5
306
Myrtille Prouté, Sophie Le Coeur, Métrey H. Tiv, Timothée Dub, Parinya Jongpaijitsakul, Anantika Ratnamhin, Chaisiri Angkurawaranon, Apinun Aramrattana, Marc Lallemant. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugsBMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-09549-w
307
Masoud Behzadifar, Hassan Abolghasem Gorji, Nicola Luigi Bragazzi. The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysisArchives of Virology 2018; 163(5): 1131 doi: 10.1007/s00705-018-3767-0
308
Jordi Remon, Francesco Passiglia, Myung-Ju Ahn, Fabrice Barlesi, Patrick M. Forde, Edward B. Garon, Scott Gettinger, Sarah B. Goldberg, Roy S. Herbst, Leora Horn, Kaoru Kubota, Shun Lu, Laura Mezquita, Luis Paz-Ares, Sanjay Popat, Kurt A. Schalper, Ferdinandos Skoulidis, Martin Reck, Alex A. Adjei, Giorgio V. Scagliotti. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and RecommendationsJournal of Thoracic Oncology 2020; 15(6): 914 doi: 10.1016/j.jtho.2020.03.006
309
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in IranHepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
310
Caitlin A. Moran, Lauren F. Collins, Nour Beydoun, Puja K. Mehta, Yetunde Fatade, Ijeoma Isiadinso, Tené T. Lewis, Brittany Weber, Jill Goldstein, Igho Ofotokun, Arshed Quyyumi, May Y. Choi, Kehmia Titanji, Cecile D. Lahiri. Cardiovascular Implications of Immune Disorders in WomenCirculation Research 2022; 130(4): 593 doi: 10.1161/CIRCRESAHA.121.319877
311
Alessandro Soria, Marco Fava, Davide P. Bernasconi, Giuseppe Lapadula, Elisa Colella, Maria G. Valsecchi, Guglielmo M. Migliorino, Roberta D'Ambrosio, Simona Landonio, Monica Schiavini, Angiola Spinetti, Canio Carriero, Elisabetta Degasperi, Giuliana Cologni, Federico Gatti, Paolo Viganò, Hamid Hasson, Caterina Uberti‐Foppa, Luisa Pasulo, Chiara Baiguera, Roberto Rossotti, Maria Vinci, Massimo Puoti, Alessia Giorgini, Barbara Menzaghi, Andrea Lombardi, Angelo Pan, Alessio Aghemo, Paolo A. Grossi, Roberto Boldizzoni, Silvia Colombo, Mauro Viganò, Maria G. Rumi, Paolo Del Poggio, Luca Valenti, Omar Giglio, Anna De Bona, Antonella d'Arminio Monforte, Alberto Colombo, Ombretta Spinelli, Marie G. Pigozzi, Chiara Molteni, Paolo Bonfanti, Natalia Terreni, Paolo Perini, Andrea Capretti, Daniele Bella, Cecilia Liani, Silvia Polo, Gianpiero Aimo, Layla Pagnucco, Sherrie Bhoori, Riccardo Centenaro, Massimo Graffeo, Antonio Ciaccio, Elena Dionigi, Sergio Lazzaroni, Isabella Carderi, Mariella Di Marco, Giuliano Rizzardini, Franco Noventa, Pietro Lampertico, Stefano Fagiuoli. Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohortLiver International 2020; 40(4): 769 doi: 10.1111/liv.14386
312
Muhammad Sohaib ASGHAR, Uzma RASHEED, Maira HASSAN, Mohammed AKRAM, Rabail YASEEN, Basmah FAYAZ. A CROSS-SECTIONAL SCREENING SURVEY ON THE SEROPREVALENCE OF HEPATITIS B AND HEPATITIS C AMONGST THE GENERAL POPULATION OF RURAL DISTRICTS OF SINDH, PAKISTANArquivos de Gastroenterologia 2021; 58(2): 150 doi: 10.1590/s0004-2803.202100000-26
313
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent mannerBiomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
314
Ahmed E. Gaafar, Amr Abd El-Aal, Mohamed Alboraie, Housam M. Hassan, Adel ElTahan, Yasser AbdelRahman, Mohamed-Naguib Wifi, Dalia Omran, Shimaa Afify Mansour, Waleed M. Hassan, Magdy Ismail, Mohamed El Kassas. Prevalence of prolonged QT interval in patients with HCV-related chronic liver diseaseThe Egyptian Heart Journal 2019; 71(1) doi: 10.1186/s43044-019-0016-0
315
Rafaela S. Fernandes, Marjorie C. L. C. Freire, Renata V. Bueno, Andre S. Godoy, Laura H. V. G. Gil, Glaucius Oliva. Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA VirusesViruses 2020; 12(6): 598 doi: 10.3390/v12060598
316
Li-Ting Xie, Chun-Hong Yan, Qi-Yu Zhao, Meng-Na He, Tian-An Jiang. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastographyWorld Journal of Gastroenterology 2018; 24(9): 957-970 doi: 10.3748/wjg.v24.i9.957
317
Vivianne de Oliveira Landgraf de Castro, Saleem Kamili, Joseph C. Forbi, Andréa Cristina Stabile, Elizeu Ferreira da Silva, Sandra Maria do Valle Leone de Oliveira, Paula Renata Tedesco de Carvalho, Marco Antonio Moreira Puga, Tayana Serpa Ortiz Tanaka, Bárbara Vieira do Lago, Mary Luiza Ibanhes, Aufra Araujo, Alexandra Tejada-Strop, Yulin Lin, Guo-Liang Xia, Amanda Sue, Sheila Araújo Teles, Ana Rita Coimbra Motta-Castro. High prevalence of Hepatitis C Virus infection among people who use crack cocaine in an important international drug trafficking route in Central-West Region BrazilInfection, Genetics and Evolution 2020; 85: 104488 doi: 10.1016/j.meegid.2020.104488
318
Timothy An, Melinda Dean, Robert Flower, Tayla Tatzenko, Hiu Tat Chan, Philip Kiely, Helen M. Faddy. Understanding occult hepatitis C infectionTransfusion 2020;  doi: 10.1111/trf.16006
319
Moosa Tatar, Susana W. Keeshin, Mark Mailliard, Fernando A. Wilson. Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United StatesJAMA Network Open 2020; 3(9): e2015756 doi: 10.1001/jamanetworkopen.2020.15756
320
Felix Kleefeld, Gabriele Arendt, Eva Neuen-Jacob, Matthias Maschke, Ingo Husstedt, Mark Obermann, Holger Schmidt, Katrin Hahn. Neurologische Komplikationen der Hepatitis-C-InfektionDer Nervenarzt 2021; 92(2): 144 doi: 10.1007/s00115-020-00999-6
321
Beatrice N. Vetter, Elena Ivanova Reipold, Stefano Ongarello, Emmanuel Fajardo, Alexander Tyshkovskiy, Iryna Ben, Marta Vasylyev. Prospective evaluation of hepatitis C virus antibody detection in whole blood collected on dried blood spots with the INNOTEST® HCV Ab IV enzyme immunoassayJournal of Clinical Virology 2021; 137: 104783 doi: 10.1016/j.jcv.2021.104783
322
Daniel Atlaw, Biniyam Sahiledengle, Zerihun Tariku. Hepatitis B and C virus infection among healthcare workers in Africa: a systematic review and meta-analysisEnvironmental Health and Preventive Medicine 2021; 26(1) doi: 10.1186/s12199-021-00983-9
323
Benedetto Caroleo, Lidia Colangelo, Maria Perticone, Giovambattista De Sarro, Luca Gallelli. Efficacy and Safety of Elbasvir-Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real-Life Clinical PracticeThe Journal of Clinical Pharmacology 2018; 58(10): 1248 doi: 10.1002/jcph.1135
324
J. Hutton, J. Doyle, R. Zordan, T. Weiland, A. Cocco, J. Howell, S. Iser, J. Snell, S. Fry, K. New, R. Sloane, M. Jarman, D. Phan, S. Tran, A. Pedrana, B. Williams, J. Johnson, S. Glasgow, A. Thompson. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency departmentInternational Journal of Drug Policy 2019; 72: 84 doi: 10.1016/j.drugpo.2019.06.021
325
Reza Safdari, Amir Deghatipour, Marsa Gholamzadeh, Keivan Maghooli. Applying data mining techniques to classify patients with suspected hepatitis C virus infectionIntelligent Medicine 2022;  doi: 10.1016/j.imed.2021.12.003
326
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno, Juan Cristina. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? World Journal of Hepatology 2021; 13(10): 1234-1268 doi: 10.4254/wjh.v13.i10.1234
327
Reinhard H. Dennin. Current HIV Prevention Policies Are Jeopardizing the “End of AIDS” Project: Realities Counteract Liberal VisionsWorld Journal of AIDS 2017; 7(02): 138 doi: 10.4236/wja.2017.72012
328
Ming-Shyan Lin, Chang-Min Chung, Ming-Ling Chang, Mei-Yen Chen, Shih-Tai Chang, Pao-Hsien Chu, Tien-Hsing Chen, Wey-Yil Lin, Tung-Jung Huang, Yu-Sheng Lin. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection ― A Nationwide Cohort Study ―Circulation Journal 2018; 82(6): 1623 doi: 10.1253/circj.CJ-17-1118
329
Xiaoqiong Duan, Xiao Liu, Wenting Li, Jacinta A. Holmes, Annie J. Kruger, Chunhui Yang, Yujia Li, Min Xu, Haiyan Ye, Shuang Li, Xinzhong Liao, Qiuju Sheng, Dong Chen, Tuo Shao, Zhimeng Cheng, Batul Kaj, Esperance A. Schaefer, Shilin Li, Limin Chen, Wenyu Lin, Raymond T. Chung. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy PathwayCells 2019; 8(4): 338 doi: 10.3390/cells8040338
330
Hui Qian, Xiaojuan Chao, Jessica Williams, Sam Fulte, Tiangang Li, Ling Yang, Wen-Xing Ding. Autophagy in liver diseases: A reviewMolecular Aspects of Medicine 2021; 82: 100973 doi: 10.1016/j.mam.2021.100973
331
Hafsa Aziz, Shazia Fatima, Mohammad Faheem. Indeterminate Prediction of Hepatitis C Virus Genotype by Commercial Real-Time Polymerase Chain Reaction Assay Resolving by Sequencing to Avoid the Consequence of Inaccurate TypingViral Immunology 2020; 33(7): 507 doi: 10.1089/vim.2019.0162
332
Bing Han, Yujia Zheng, Le Wang, Haixu Wang, Jiaxin Du, Fanglei Ye, Tongwen Sun, Lianfeng Zhang. A novel microRNA signature predicts vascular invasion in hepatocellular carcinomaJournal of Cellular Physiology 2019; 234(11): 20859 doi: 10.1002/jcp.28690
333
Claudinei Mesquita da SILVA, Leyde Daiane de PEDER, Mateus Vailant THOMAZELLA, Jorge Juarez Vieira TEIXEIRA, Dennis Armando BERTOLINI. PROFILE OF HCV GENOTYPES AND HIV-SUBTYPES AMONG HIV-COINFECTED PATIENTS IN SOUTHERN BRAZILArquivos de Gastroenterologia 2019; 56(4): 344 doi: 10.1590/s0004-2803.201900000-68
334
Qunying Han, Xiude Fan, Xiaoyun Wang, Ye Wang, Huan Deng, Xiaoge Zhang, Kun Zhang, Na Li, Zhengwen Liu. High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world settingVirology Journal 2019; 16(1) doi: 10.1186/s12985-019-1184-y
335
Mona Prasad, George R. Saade, Grecio Sandoval, Brenna L. Hughes, Uma M. Reddy, Lisa Mele, Ashley Salazar, Michael W. Varner, Cynthia Gyamfi-Bannerman, John M. Thorp, Alan T. N. Tita, Geeta K. Swamy, Edward K. Chien, Brian M. Casey, Alan M. Peaceman, Yasser Y. El-Sayed, Jay D. Iams, Ronald S. Gibbs, Baha Sibai, Nicholas Wiese, Saleem Kamili, George A. Macones. Hepatitis C Virus Antibody Screening in a Cohort of Pregnant WomenObstetrics & Gynecology 2020; 135(4): 778 doi: 10.1097/AOG.0000000000003754
336
Kazem Baesi, Ali Akbar Velayati, Masoumeh Farrokh Ashtiani, Kamal Fakhredini, Mohammad Banifazl, Mona Sadat Larijani, Parya Basimi, Amitis Ramezani. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected PatientsCurrent HIV Research 2021; 19(5): 391 doi: 10.2174/1566523221666210707142838
337
Sanja Kiprijanovska, Emilija Sukarova Stefanovska, Predrag Noveski, Viktorija Chaloska Ivanova, Dijana Plaseska-Karanfilska. Influence of OASL gene polymorphisms on host response to interferon therapy in chronic hepatitis C virus patientsThe EuroBiotech Journal 2017; 1(2): 117 doi: 10.24190/ISSN2564-615X/2017/02.02
338
Rohan Janardhan Meshram, Gunderao Hanumantrao Kathwate, Rajesh Nivarti Gacche. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infectionsArchives of Virology 2022; 167(3): 717 doi: 10.1007/s00705-022-05375-0
339
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent ProcessInternational Journal of Molecular Sciences 2019; 20(9): 2332 doi: 10.3390/ijms20092332
340
Marta Miarons, Azhara Sánchez-Ulayar, Glòria Sempere, Sergio Marín, Josep Maria Castellví. New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groupsEuropean Journal of Hospital Pharmacy 2019; 26(3): 135 doi: 10.1136/ejhpharm-2017-001352
341
Dinesh Jothimani, Radhika Venugopal, Mukul Vij, Mohamed Rela. Post liver transplant recurrent and de novo viral infectionsBest Practice & Research Clinical Gastroenterology 2020; : 101689 doi: 10.1016/j.bpg.2020.101689
342
Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching Lung Lai, Henry Lik-Yuen Chan, Lai Wei. Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infectionJournal of Viral Hepatitis 2018; 25(12): 1429 doi: 10.1111/jvh.12965
343
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro-cardiovascular disease: analysis of a national population-based survey in EgyptTropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
344
Yu Xiang, Xiao-fei Lai, Pu Chen, Yang Yang. The correlation of HCV RNA and HCV core antigen in different genotypes of HCVJournal of Clinical Laboratory Analysis 2019; 33(1): e22632 doi: 10.1002/jcla.22632
345
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic reviewJournal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
346
Linh Tran, Mai Nhu Y, Thai Le Ba Nghia, Abdulrahman Hendam, Nguyen Lam Vuong, Ebrahim Alzalal, Ahmed M. Sayed, Mustafa Mushtaq Hussain, Akash Sharma, Thuan Tieu, Peterson Gitonga Mathenge, Kenji Hirayama, Neal Alexander, Nguyen Tien Huy. Frequent inappropriate use of unweighted summary statistics in systematic reviews of pathogen genotypes or genogroupsJournal of Clinical Epidemiology 2020; 119: 26 doi: 10.1016/j.jclinepi.2019.11.009
347
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen E. Abechi. Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitorsBulletin of the National Research Centre 2021; 45(1) doi: 10.1186/s42269-020-00467-w
348
Elena Chernykh, Olga Leplina, Ekaterina Oleynik, Marina Tikhonova, Tamara Tyrinova, Natalia Starostina, Alexandr Ostanin. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial)Immunologic Research 2018; 66(1): 31 doi: 10.1007/s12026-017-8967-2
349
Lubomír Skladaný, Marian Oltman, Soňa Fraňková, Sylvia Dražilová, Petr Husa, Jan Šperl, Václav Hejda, Petr Urbánek, Svetlana Adamcová-Selčanová, Martin Janičko, Pavol Kristian, Viera Kupčová, Marek Rác, Ivan Schréter, Ladislav Virág, Adriana Liptáková, Miriam Ondrášová, Peter Jarčuška. Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristicsInternational Journal of Public Health 2020; 65(9): 1723 doi: 10.1007/s00038-020-01496-y
350
Ifeyinwa M. Okafor, Solomon O. Ugwu, Henshaw U. Okoroiwu. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prisonBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01504-8
351
Rowan Ahmed, Roaa Kareem, Nanditha Venkatesan, Rinky A Botleroo, Opemipo D Ogeyingbo, Renu Bhandari, Mallika Gyawali, Abeer O Elshaikh. Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus InfectionCureus 2021;  doi: 10.7759/cureus.17237
352
Di Wu, Shiping Hu, Guozi Chen, Longjiao Chen, Jian Liu, Wenlin Chen, Youwen Lv, Xiaoni Chen, Shan Lin, Fenfang Wu. Association of hepatitis C infection and risk of kidney cancer: A systematic review and meta‐analysis of observational studiesJournal of Viral Hepatitis 2021; 28(2): 226 doi: 10.1111/jvh.13434
353
Ling-Xiao Qu, Yang Shi, Kai-Yun Chen, Yi-Han Lu, Hong Ren. The distribution of hepatitis C virus infection in Shanghai, China: a time-spatial studyBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06577-8
354
Hany M. Elsadek, Elsayed S. Abdelbaser, Mohamed H. Emara, Hanan H. Soliman, Alaa A. Farag. Morbidity and mortality during hepatitis C treatment using sofosbuvir and daclatasvir with or without ribavirin, in a cohort of Egyptian patientsEuropean Journal of Gastroenterology & Hepatology 2020; 32(8): 1046 doi: 10.1097/MEG.0000000000001695
355
José A. Gálvez, Rafael Clavería-Gimeno, Juan J. Galano-Frutos, Javier Sancho, Adrian Velázquez-Campoy, Olga Abian, María D. Díaz-de-Villegas. Stereoselective synthesis and biological evaluation as inhibitors of hepatitis C virus RNA polymerase of GSK3082 analogues with structural diversity at the 5-positionEuropean Journal of Medicinal Chemistry 2019; 171: 401 doi: 10.1016/j.ejmech.2019.03.019
356
Lai Wei, Guiqiang Wang, Negar N Alami, Wen Xie, Jeong Heo, Qing Xie, Mingxiang Zhang, Yoon Jun Kim, Seng Gee Lim, Linda M Fredrick, Wenjing Lu, Wei Liu, Hari V Kalluri, Preethi Krishnan, Rakesh Tripathi, Niloufar Mobashery, Margaret Burroughs, Armen Asatryan, Jidong Jia, Jinlin Hou. Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)The Lancet Gastroenterology & Hepatology 2020; 5(9): 839 doi: 10.1016/S2468-1253(20)30086-8
357
Talaat Zakareya, Mostafa Elhelbawy, Hassan Elzohry, Mohamed Eltabbakh, Mohamed Deif, Mohamed Abbasy, Tatsuo Kanda. Long-Term Impact of Hepatitis C Virus Eradication on Liver Stiffness in Egyptian PatientsCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/4961919
358
Elisabete Andrade, Daniele Rocha, Marcela Fontana-Maurell, Elaine Costa, Marisa Ribeiro, Daniela Tupy de Godoy, Antonio G.P. Ferreira, Amilcar Tanuri, Patrícia Alvarez, Rodrigo Brindeiro. One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in BrazilThe Brazilian Journal of Infectious Diseases 2018; 22(5): 418 doi: 10.1016/j.bjid.2018.08.003
359
Kaho H. Tisthammer, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings. Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3aViruses 2021; 13(3): 511 doi: 10.3390/v13030511
360
Christine Chang, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu. Hepatitis C core antigen highly correlated to HCV RNAThe Kaohsiung Journal of Medical Sciences 2018; 34(12): 684 doi: 10.1016/j.kjms.2018.08.002
361
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76135
362
Adel A Alhazmi, Alhanouf Almuflihi, Mohammed M Aly, Abdelgaffar Mohammed, Abdulrahman Alshehri. Hepatitis C-induced Sjögren’s Syndrome With Positive Serology: A Case ReportCureus 2021;  doi: 10.7759/cureus.20091
363
Yu. V. Ostankova, D. E. Valutite, E. B. Zueva, E. N. Serikova, A. N. Shchemelev, S. Boumbaly, T. A.L. Balde, A. V. Semenov. Primary HCV Drug Resistance Mutations in Patients with Newly Diagnosed HIV InfectionProblems of Particularly Dangerous Infections 2020; (3): 97 doi: 10.21055/0370-1069-2020-3-97-105
364
T.L. Hrydina . PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. ReviewMedical Science of Ukraine (MSU) 2022; 18(1): 64 doi: 10.32345/2664-4738.1.2022.09
365
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Margherita Macera, Evangelista Sagnelli, Mariantonietta Pisaturo. Epidemiology and management of hepatitis C virus infections in immigrant populationsInfectious Diseases of Poverty 2019; 8(1) doi: 10.1186/s40249-019-0528-6
366
Dorota Zarębska-Michaluk. Genotype 3-hepatitis C virus’ last line of defenseWorld Journal of Gastroenterology 2021; 27(11): 1006-1021 doi: 10.3748/wjg.v27.i11.1006
367
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen. Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in AsiaBMJ Open Gastroenterology 2018; 5(1): e000209 doi: 10.1136/bmjgast-2018-000209
368
Bing-Ru Wu, Auda A. Eltahla, Elizabeth Keoshkerian, Melanie R. Walker, Alex Underwood, Nicholas A. Brasher, David Agapiou, Andrew R. Lloyd, Rowena A. Bull. A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramersJournal of Immunological Methods 2019; 472: 65 doi: 10.1016/j.jim.2019.06.016
369
Lin Li, Xian Jiang, Lixin Fu, Liwen Zhang, Yanyan Feng. Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysisClinical and Experimental Medicine 2022;  doi: 10.1007/s10238-022-00827-y
370
Yu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, Jessica Tan, Kwong Ming Fock, Ngai Moh Law, Weiquan Li, Andrew Kwek, Yu Bin Tan, Jingyun Koh, Zheng Cong Lee, Loshini Senthil Kumar, Eng Kiong Teo, Tiing‐Leong Ang. Efficacy and safety of sofosbuvir/velpatasvir in a real‐world chronic hepatitis C genotype 3 cohortJournal of Gastroenterology and Hepatology 2021; 36(5): 1300 doi: 10.1111/jgh.15324
371
Kimia Kardani, Parya Basimi, Mehrshad Fekri, Azam Bolhassani. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine developmentExpert Review of Clinical Pharmacology 2020; 13(9): 1001 doi: 10.1080/17512433.2020.1814743
372
Elodie Laugel, Cédric Hartard, Hélène Jeulin, Sibel Berger, Véronique Venard, Jean‐Pierre Bronowicki, Evelyne Schvoerer. Full‐length genome sequencing of RNA viruses—How the approach can enlighten us on hepatitis C and hepatitis E virusesReviews in Medical Virology 2021; 31(4) doi: 10.1002/rmv.2197
373
Jean Damascene Makuza, Carol Y. Liu, Corneille Killy Ntihabose, Donatha Dushimiyimana, Sabine Umuraza, Marie Paul Nisingizwe, Justine Umutesi, Janvier Serumondo, Soline Dusabeyesu Mugeni, Muhamed Semakula, Neil Gupta, Margaret Hellard, Sabin Nsanzimana. Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening programBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4322-7
374
Shah Jahan Shayan, Rajab Nazari, Frank Kiwanuka. Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysisHarm Reduction Journal 2021; 18(1) doi: 10.1186/s12954-021-00505-4
375
Kuhu Chatterjee, Rohit Gupta, Balram Ji Omar, Pratima Gupta, Deepjyoti Kalita. Genotypic distribution of hepatitis C virus in UttarakhandIndian Journal of Medical Microbiology 2021; 39(4): 479 doi: 10.1016/j.ijmmb.2021.06.009
376
Mortada El‐Shabrawi, Sherif Baroudy, Fetouh Hassanin, Ahmed Saed Behairy, Mostafa Yakoot, Ayaat Ahmed. Follow‐up of chronic paediatric hepatitis C virus in a low‐/middle‐income countryActa Paediatrica 2020; 109(12): 2699 doi: 10.1111/apa.15333
377
Detection Of Hepatitis C Virus (Hcv) Infection And Its Genotype In Patients At Hepatology Outpatient Clinic, Dr Soetomo General Hospital, Surabaya.IOP Conference Series: Earth and Environmental Science 2019; 217: 012051 doi: 10.1088/1755-1315/217/1/012051
378
David Powell, Abby Alpert, Rosalie L. Pacula. A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis CHealth Affairs 2019; 38(2): 287 doi: 10.1377/hlthaff.2018.05232
379
Shakir Abdulrahman Jamal, Ibrahim Abdulqader Naqid, Nawfal Rasheed Hussein, Solav Rashed Abdulqader, Avan Ali Nimet, Haider Adil Abdulkhdair, Ramyar Abubakr Qader. The Prevalence of Hepatitis B and C Virus Infections in the Couples Attending a Premarital Screening Program in Zakho City, Kurdistan Region of IraqZahedan Journal of Research in Medical Sciences 2021; (In Press) doi: 10.5812/zjrms.99405
380
Norah A. Terrault, Miriam T. Levy, Ka Wang Cheung, Gonzague Jourdain. Viral hepatitis and pregnancyNature Reviews Gastroenterology & Hepatology 2021; 18(2): 117 doi: 10.1038/s41575-020-00361-w
381
Poramate Pitak-Arnnop, Keskanya Subbalekha, Nattapong Sirintawat, Chatpong Tangmanee, Prim Auychai, Chayawee Muangchan, Passanesh Sukphopetch, Jean-Paul Meningaud, Andreas Neff. Are oral lichen planus patients at high risk of hepatitis C? A case-control studyJournal of Stomatology, Oral and Maxillofacial Surgery 2022; 123(3): e37 doi: 10.1016/j.jormas.2021.07.013
382
Mohamed M. Nabeel, Rania K. Darwish, Wafaa Alakel, Rabab Maher, Hossam Mostafa, Ahmed Hashem, Mohamed Elbeshlawy, Amr Abul-Fotouh, Hend I. Shousha, Mohamad Saeed Marie. Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot StudyJournal of Clinical and Experimental Hepatology 2022; 12(2): 428 doi: 10.1016/j.jceh.2021.06.018
383
Melina Santos, Camelia Protopopescu, Elizabeth Delarocque‐Astagneau, Marc Bourlière, Ventizlava Petrov‐Sanchez, Vincent Di Beo, Dominique Larrey, Maël Baudoin, Céline Dorival, Morgane Bureau, Hélène Fontaine, Fabrice Carrat, Fabienne Marcellin, Stanislas Pol, Patrizia Carrieri. Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)Liver International 2022; 42(1): 38 doi: 10.1111/liv.15056
384
Adam Trickey, Hannah Fraser, Aaron G. Lim, Josephine G. Walker, Amy Peacock, Samantha Colledge, Janni Leung, Jason Grebely, Sarah Larney, Natasha K. Martin, Louisa Degenhardt, Matthew Hickman, Margaret T. May, Peter Vickerman. Modelling the potential prevention benefits of a treat‐all hepatitis C treatment strategy at global, regional and country levels: A modelling studyJournal of Viral Hepatitis 2019; 26(12): 1388 doi: 10.1111/jvh.13187
385
Mohamed A. Daw, Lutfi A. Buktir Ali, Amina M. Daw, Nadia E. M. Sifennasr, Aghnyia A. Dau, Mohamed M. Agnan, Abdallah El-Bouzedi. The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3471-4
386
Aysegul Ozakyol. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)Journal of Gastrointestinal Cancer 2017; 48(3): 238 doi: 10.1007/s12029-017-9959-0
387
Ankit Ganeshpurkar, Gopichand Gutti, Sushil Kumar Singh. Viral Polymerases2019; : 1 doi: 10.1016/B978-0-12-815422-9.00001-2
388
Sarah Gander, Angela Morris, Stefanie Materniak. An Evaluation of Hepatitis C Screening in Infants and Children Born to Seropositive Mothers in Saint John, New BrunswickCureus 2021;  doi: 10.7759/cureus.17377
389
Curtis Mabilangan, Catherine Burton, Sheila O’Brien, Sabrina Plitt, Dean Eurich, Jutta Preiksaitis. Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein–Barr virus in Canada: A cross-sectional studyOfficial Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(3): 158 doi: 10.3138/jammi-2020-0005
390
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi, Navid Nezafat. Designing a Fusion Protein Vaccine Against HCV: An In Silico ApproachInternational Journal of Peptide Research and Therapeutics 2019; 25(3): 861 doi: 10.1007/s10989-018-9735-4
391
Luis Filipe da Costa Marques Borges, Mariano Gustavo Zalis, Guilherme Santoro-Lopes, Rafael Brandão Varella. Hepatitis C virus genotypes in hemodialysis patients in AngolaJournal of Medical Virology 2019; 91(3): 518 doi: 10.1002/jmv.25354
392
Yu Jeong Choi, Boyeon Kim, Yoonjung Kim, Kyung-A Lee. Performance Evaluation of Aptima HBV and HCV Quant Assays in the Panther SystemLaboratory Medicine Online 2021; 11(3): 177 doi: 10.47429/lmo.2021.11.3.177
393
Qi Wu, Zhubing Li, Qiang Liu. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTENVirology 2018; 520: 94 doi: 10.1016/j.virol.2018.05.011
394
Fiona McPhee, Joseph Ueland, Vincent Vellucci, Scott Bowden, William Sievert, Nannan Zhou. Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the In Vitro Potency of Direct-Acting Antiviral Agents Antimicrobial Agents and Chemotherapy 2019; 63(4) doi: 10.1128/AAC.02205-18
395
Tapas Patra, Ratna Ray, Ranjit Ray. Strategies to Circumvent Host Innate Immune Response by Hepatitis C VirusCells 2019; 8(3): 274 doi: 10.3390/cells8030274
396
Masako Okada, Hoang Hai, Akihiro Tamori, Sawako Uchida-Kobayashi, Masaru Enomoto, Hiromitsu Kumada, Norifumi Kawada. Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virusClinical Journal of Gastroenterology 2019; 12(3): 213 doi: 10.1007/s12328-018-0922-9
397
Panita Mettikanont, Chalermrat Bunchorntavakul, K. Rajender Reddy. Systematic review: epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infectionAlimentary Pharmacology & Therapeutics 2019; 49(5): 492 doi: 10.1111/apt.15100
398
Nawfal R Hussein, Hashim A Sharaf, Shaveen Mahdi. The Prevalence of Hepatitis C Virus Infection in Pregnant Women in Duhok City, Kurdistan Region of Iraq: A Brief ReportWomen’s Health Bulletin 2019; (In Press) doi: 10.5812/whb.91494
399
Winita Hardikar. Viral hepatitisJournal of Paediatrics and Child Health 2019; 55(9): 1038 doi: 10.1111/jpc.14562
400
Rachel E. Gicquelais, Betsy Foxman, Joseph Coyle, Marisa C. Eisenberg. Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillanceEpidemics 2019; 27: 86 doi: 10.1016/j.epidem.2019.02.003
401
Joost W. Geenen, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels. Accuracy of budget impact estimations and impact on patient access: a hepatitis C case studyThe European Journal of Health Economics 2019; 20(6): 857 doi: 10.1007/s10198-019-01048-z
402
Ali Hamza, Iftikhar Ahmad, Muhammad Uneeb. Fuzzy logic and Lyapunov‐based non‐linear controllers for HCV infectionIET Systems Biology 2021; 15(2): 53 doi: 10.1049/syb2.12014
403
Hosnieh Fathi, Andrew Clark, Nathan R. Hill, Geoffrey Dusheiko. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic reviewBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2820-z
404
Henrique Pott, Matheus Theodoro, Juliana de Almeida Vespoli, Jorge Figueiredo Senise, Adauto Castelo. Mother-to-child transmission of hepatitis C virusEuropean Journal of Obstetrics & Gynecology and Reproductive Biology 2018; 224: 125 doi: 10.1016/j.ejogrb.2018.03.034
405
Sayed Muh Reza Mousawee, Maryam Moossavi, Afsane Bahrami, Hamidullah Rasekh, Mohammad Sadegh Naghizadeh, Hassn Abd, Mohammad Fereidouni. The Prevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Viral Infections Among a Large Population of AfghansHepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.101012
406
Ilya Bendich, Steven Takemoto, Joseph T. Patterson, Alexander Monto, Thomas C. Barber, Alfred C. Kuo. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US VeteransThe Journal of Arthroplasty 2019; 34(7): S319 doi: 10.1016/j.arth.2019.02.052
407
Markus Reiser, Bianka Wiebner, Jürgen Hirsch. Neural-network analysis of socio-medical data to identify predictors of undiagnosed hepatitis C virus infections in Germany (DETECT)Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1832-4
408
Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng. The changing epidemiology of liver diseases in the Asia–Pacific regionNature Reviews Gastroenterology & Hepatology 2019; 16(1): 57 doi: 10.1038/s41575-018-0055-0
409
Douglas J. Pryce. Refugee Health Care2020; : 97 doi: 10.1007/978-3-030-47668-7_7
410
Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, Verónica Briz, Inês Moranguinho, Fátima Serejo, José Fernando Velosa, Rui Tato Marinho, Pedro Borrego, Nuno Taveira. Epidemic history of hepatitis C virus genotypes and subtypes in PortugalScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30528-0
411
Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Piérard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M. Rodrigues, Tamara Vanhaecke. Infections at the nexus of metabolic-associated fatty liver diseaseArchives of Toxicology 2021; 95(7): 2235 doi: 10.1007/s00204-021-03069-1
412
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Po-Cheng Liang, Ming-Yen Hsieh, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Jin-Ching Lee, Pei-Lun Lee, Chia-Yen Dai. Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patientsJournal of Gastroenterology and Hepatology 2018; 33(11): 1897 doi: 10.1111/jgh.14275
413
Roya Kahyesh‐Esfandiary, Zohreh‐Azita Sadigh, Maryam Esghaei, Mohammad‐Navid Bastani, Tahereh Donyavi, Alireza Najafi, Atousa Fakhim, Farah Bokharaei‐Salim. Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta‐thalassemia major: Occult HCV infectionJournal of Medical Virology 2019; 91(1): 107 doi: 10.1002/jmv.25279
414
Salvo Danilo Lombardo, Sebastiano Lombardo. Global stability for a mathematical model of hepatitis C: Impact of a possible vaccination with DAAs therapyRENEWABLE ENERGY SOURCES AND TECHNOLOGIES 2019; 2161: 030020 doi: 10.1063/1.5127485
415
EMILY HAMBURG-SHIELDS, MONA PRASAD. Infectious Hepatitis in PregnancyClinical Obstetrics & Gynecology 2020; 63(1): 175 doi: 10.1097/GRF.0000000000000512
416
Tsung-Lung Tsai, Huei-Min Jhou, Frank S Fan. Conspicuous Response to Direct-Acting Antivirals in Chronic Hepatitis C-related Immune Thrombocytopenia: A Case ReportCureus 2022;  doi: 10.7759/cureus.24193
417
K. G. Young, K. Haq, S. MacLean, R. Dudani, S. M. Elahi, R. Gilbert, R. D. Weeratna, L. Krishnan. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigensJournal of Viral Hepatitis 2018; 25(6): 649 doi: 10.1111/jvh.12856
418
Antonio Travaglino, Silvia Varricchio, Mirella Pace, Adriana Iuliano, Marco Picardi, Fausto Tranfa, Stefania Staibano, Massimo Mascolo. Hepatitis C virus in MALT-lymphoma of the ocular adnexaPathology - Research and Practice 2020; 216(4): 152864 doi: 10.1016/j.prp.2020.152864
419
Muhammad Junaid Azhar, Noor Khalid, Shanza Azhar, Umer Irshad, Hassaan Ahmed, Tayyab Mumtaz Khan, Samat Habib , Zuha Ali, Yumnah Anwar, Muhammad Bilal. Study of the Effect of Different Hepatitis C Virus Genotypes on SplenomegalyCureus 2020;  doi: 10.7759/cureus.10164
420
Ashwin Rammohan. Current management & future directions in post-liver transplant recurrence of viral hepatitisJournal of Liver Transplantation 2021; 3: 100027 doi: 10.1016/j.liver.2021.100027
421
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
422
Hossam Gewaid, Haruyo Aoyagi, Minetaro Arita, Koichi Watashi, Ryosuke Suzuki, Shota Sakai, Keigo Kumagai, Toshiyuki Yamaji, Masayoshi Fukasawa, Fumihiro Kato, Takayuki Hishiki, Ayako Mimata, Yuriko Sakamaki, Shizuko Ichinose, Kentaro Hanada, Masamichi Muramatsu, Takaji Wakita, Hideki Aizaki, Mark T. Heise. Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in Hepatitis C Virus RNA Replication FactoriesJournal of Virology 2020; 94(23) doi: 10.1128/JVI.01080-20
423
Mei-Yueh Lee, Wei-Chun Chen, Wei-Hao Hsu, Szu-Chia Chen, Jin-Ching Lee. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent MechanismInternational Journal of Molecular Sciences 2019; 20(18): 4569 doi: 10.3390/ijms20184569
424
Kazeem Adeboyejo, Victória Riquena Grosche, Diego Pandeló José, Giulia Magalhães Ferreira, Jacqueline Farinha Shimizu, Barnabas J. King, Alexander W. Tarr, Márcia Maria Costa Nunes Soares, Jonathan K. Ball, C. Patrick McClure, Ana Carolina Gomes Jardim. Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil Access Microbiology 2022; 4(3) doi: 10.1099/acmi.0.000326
425
Asma Ahsan, Saira Dar, Fareeha Hassan, Farkhanda Ghafoor, Muhammad Haroon Yousuf, Syed Shahzad-ul-Hussan, Sripathi M Sureban. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virusPLOS ONE 2021; 16(8): e0256816 doi: 10.1371/journal.pone.0256816
426
Sang Hoon Ahn, Won Hyeok Choe, Yoon Jun Kim, Jeong Heo, Dorota Latarska-Smuga, Jiho Kang, Seung Woon Paik. Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis CGut and Liver 2020; 14(3): 368 doi: 10.5009/gnl18100
427
Marwa S. Abdel-Tawab, Hanan H. Fouad, Dalia A. Omran, Aml E. Abdou, Shaimaa Mohamed Zaied, Alaa A. Mohamed, Dorota Formanowicz. Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian PatientsBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8879758
428
Navaneethan Palanisamy, Dario Akaberi, Johan Lennerstrand. Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and HepacivirusMolecular Phylogenetics and Evolution 2018; 118: 58 doi: 10.1016/j.ympev.2017.09.015
429
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Immunopathogenesis of Liver Injury During Hepatitis C Virus InfectionViral Immunology 2019; 32(3): 112 doi: 10.1089/vim.2018.0124
430
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infectionAdvanced Drug Delivery Reviews 2021; 168: 134 doi: 10.1016/j.addr.2020.05.010
431
H Elalfy, T Besheer, MA El-Maksoud, K Farid, M Elegezy, AM El Nakib, MA El-Aziz, AA El-Khalek, A El-Morsy, A Elmokadem, AZ Elsamanoudy, M El-Bendary. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolizationBritish Journal of Biomedical Science 2018; 75(4): 187 doi: 10.1080/09674845.2018.1494769
432
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Biyao Zou, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen. Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysisBMJ Open Gastroenterology 2018; 5(1): e000207 doi: 10.1136/bmjgast-2018-000207
433
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ali M. Bazzi, Wadha A. Alfouzan, Shahab A. Alsuliman, Fatimah A. Aldrazi, Shafiul Haque. Overview of hepatitis C infection, molecular biology, and new treatmentJournal of Infection and Public Health 2020; 13(5): 773 doi: 10.1016/j.jiph.2019.11.015